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Cell-cycle checkpoint proteins help maintain genomic integrity by sensing damaged DNA and initiating 
DNA repair or apoptosis. Checkpoint protein activation to cell-cycle damaging agents can involve post-
translational modifications and these alterations provide a means to determine whether DNA in a cell is 
damaged or not. Steinmoeller et al. (2009) showed that checkpoint proteins are suitable biomarkers for 
detecting genotoxins in Oncorhynchus mykiss (rainbow trout). In this project, two evolutionarily 
conserved checkpoint proteins, Rad1 and Hus1, have been cloned from rainbow trout and antibodies 
against these proteins were developed. This is the first time that either Rad1 or Hus1 has been 
characterized in rainbow trout. For rtRad1, it was determined that the open-reading frame was 840bp, 
which encodes 279aa with a predicted protein size of 31kDa. The rtRad1 amino-acid sequence is highly 
conserved and contains conserved exonuclease and leucine zipper domains. RT-PCR was used to identify 
alternatively spliced variants of rtRad1 and it appears that these variants encode different sized Rad1 
proteins that are tissue and cell-line specific.  A Rad1 splice variant that encodes an 18kDa protein 
appears to be abundant only in heart tissue and in the RTgill-W1 and RTbrain-W1 cell-lines. A 
genotoxicity study was completed where RTgill-W1 and RTbrain-W1 cells were treated with bleomycin, 
which induces double-stranded DNA breaks. In RTgill-W1, levels of an 18kDa Rad1 protein increased in 
a dose-dependent manner while in RTbrain-W1 the Rad1 levels remained the same.  It appears that this 
18kDa Rad1 protein may be directly involved in maintaining genomic integrity and shows potential to be 
used as a genotoxicity biomarker. This is the first time that an isoform of Rad1 has shown to be modified 
in the presence of a damaging agent. Both Rad1 and Hus1 need to be further characterized to determine 
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1.1 An overview of the cell-cycle 
In 1953, Howard and Pelc first described the eukaryotic cell-cycle time-course using 
32
P isotope labeled 
Vicia faba L. plants. The authors proposed that cells had a pre-DNA synthesis phase (G1), a DNA 
synthesis phase (S), a pre-cell division phase (G2) and cell division phase (D), which is known today as 
M or Mitosis (Steel, 1986).  Since this time the individual phases have been characterized more 
thoroughly and a new phase (G0) has been introduced. Summarizing the cell-cycle in four phases does 
not do its intrinsic complexity justice. Intricate biochemical pathways regulate the transition from phase-
to-phase to ensure the integrity of DNA (Hartwell and Weinert, 1989).  There are many abbreviations 
used when explaining the cell-cycle and cell-cycle checkpoints and a list of all abbreviations are given on 
page III/IV.  
1.1.1 Cell-cycle phases 
The five stages of the cell-cycle are G0, G1, S, G2, and M. The three gap (G) phases, G0, G1 and G2, are 
preparation phases which allow the cell to transition into the next step.  DNA is replicated during S-phase 
and in M-phase the duplicated DNA is separate into different nuclei and the cell splits equally forming 
two identical daughter cells (Johnson and Walker, 1999; Malumbres and Barbacid, 2009). M-phase 
includes 5 sub-phases: (1) prophase; (2) prometaphase; (3) metaphase; (4) anaphase; (5) telephase or 
cytokinesis. Furthermore, all phase transitions are driven by the family of proteins referred to as cyclins, 
which activate cyclin-dependent kinases (CDKs) (Coller, 2007; Malumbres and Barbacid, 2009).  A 






Figure 1.1: The eukaryotic cell-cycle: as the clock ticks  
The four phases of the cell-cycle G1, S, G2 and M are shown. The out of cycle phase (dotted loop), G0, is 
placed prior to the G1 restriction point. Cyclin and cyclin-dependent complexes (CDKs) drive the phase 
transitions. Cyclin A/E-CDK1 drive the G1 phase while cyclin A-CDK1 drives S phase. The transition 
from G2 to M-phase requires the degradation of A-type cyclins and the formation of B-type cyclins. Cell 
progression up until metaphase is driven by CDK1-cyclin B. Afterwards, progression involves the 
anaphase-promoting complex (APC). The 4 cell-cycle checkpoints (1) G1/S checkpoint; (2) Intra-S 
checkpoint; (3) G2/M checkpoint; (4) spindle assembly checkpoint (SAC) are indicated.  This figure was 





The quiescent phase, called G0, refers to the „out-of-cycle‟ state that cells remain in before proceeding to 
G1-phase.  How the G0 phase operates and its direct role has been under scrutiny for many years 
(reviewed in Coller, 2007).  G0 occurs right after Mitosis and before the restriction point in G1 phase. 
The restriction point is the point of the cell-cycle where cells are no longer influenced by external signals, 
such as stress and nutrient levels, and are 100% committed to completing the cell-cycle (Coller, 2007). 
Prior to the restriction point the cell may remain in the G0-phase if they are not needed. E2F proteins are 
transcription factors that regulate expression of essential genes needed for DNA synthesis (Johnson and 
Walker, 1999; Sun et al., 2007).  Cell-division cycle 6 (CDC6), is an E2F target that is essential for DNA 
synthesis. The loading of CDC6 onto chromatin allows for origin firing and is the determining factor 
behind a cell‟s future (Coller, 2007; Borlado and Mendez, 2008).  Details on origin firing and CDC6 will 
be discussed in section 1.1.3. 
The re-entry of quiescent cells into the cell-cycle is determined mainly by retinoblastoma protein 
(pRb). Unphosphorylated pRb binds to E2F making it a transcriptional repressor (Johnson and Walker, 
1999; Sun et al., 2007).  When the cell is needed, external signals increase levels of E-type cyclins which 
work with CDK2 to phosphorylate pRb. Phosphorylated pRb disconnects from E2F which allows E2F to 
promote the transcription of genes involved in the cell-cycle.  The pRb works with E2F to ensure that 
expression of genes required for synthesis are repressed until S-phase (Sun et al., 2007). 
1.1.3 G1-phase 
The initiation of DNA synthesis and the firing of replication origins occur in G1-phase. It is here that 
CDC6 in association with the origin replication complex (ORC), chromatin licensing and DNA 
replication factor 1 (CDT1) and minichromosome maintenance proteins 2-7 (MCM2-7) control the firing 
of replication origins.  The transition from G1 to S-phase is controlled by CDK2‟s association with E-type 
cyclins.  The CDK2-cyclin-E complex phosphorylates pBr which disconnects it from E2F and leaves E2F 
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active to promote the transcription of genes which are necessary for  DNA replication (Johnson and 
Walker, 1999; Coller, 2007; Malumbres and Barbacid, 2009). 
1.1.4 S-phase 
The objective of S-phase is to replicate DNA only once and to ensure that no errors have occurred. DNA 
replication is initiated when the multi-subunit ORC recruits CDC6 and CDT1 and forms the CDC6-
CDT1-ORC- DNA complex. This complex loads the MCM2-7 complex onto chromatin and at this stage 
the combined proteins are called the pre-replication complex (preRC). The preRC activates the initiation 
complex which consists of replication protein A (RPA), cell division cycle protein 45 (Cdc45) and the go-
inchi-ni-san (GIN) complex (Broderick and Nasheuer, 2009; Malumbres and Barbacid, 2009). The 
initiation complex activates DNA polymerase α-primase (Pol-prim) and the replicative helicase complex: 
essentially, this is the start of DNA replication.  As the replicative helicase complex unwinds DNA, 
topoisomerase 1 (TOP1) nicks the upstream DNA backbone strands to ease the stress of supercoiled DNA 
allowing pol-prim to elongate the DNA by adding RNA primers (Broderick and Nasheuer, 2009; Maya-
Mendoza et al., 2009).  The replication factor C (RFC) complex loads the proliferating cell nuclear 
antigen (PCNA) onto DNA at which time pol-prim gets replaced by the proofreading polymerase, pol-δ. 
Discontinuous synthesis on the lagging strand occurs due to this replacement and creates Okazaki 
fragments. The fragments are joined together by RNAse H, flap endonuclease 1 (Fen1) and DNA ligase 1 
(Broderick and Nasheuer, 2009).  After replication is complete, CDKs promote the phosphorylation of 
CDT1 and CDC6 causing degradation of CDT1 by proteasomes and nuclear export of CDC6 into the 
cytoplasm, where it cannot initiate replication firing until the next cell-cycle (Coller, 2007). The 
completion of S-phase results in two identical DNA duplexes which are maintained in the nucleus. The 





During G2, the processes needed for mitosis are finalized to ensure chromosome stability. The 
precentriol, which was synthesized in G1 and S-phase, duplicate and become two functional pairs of 
centrosomes.  Centrosomes are non-membranous organelles that form the bipolar spindles which are 
responsible for the separation of sister chromatid during mitosis (Wang et al., 2009). The transition from 
G2 to mitosis requires the degradation of A-type cyclins and the formation of B-type cyclins (Malumbres 
and Barbacid, 2009). 
1.1.6 Mitosis 
Sister chromatids are held together by cohesin, a multiprotein complex, as they travel from G2 to the first 
step in mitosis, prophase. This transition activates CDK1, Polo-like kinase 1 (PLK1) and Aurora B5, 
which in turn form the mitotic spindles. The transition from prophase to the second step in mitosis, 
premetaphase,  involves the degradation of A-type cyclins and the formation of CDK1-cyclin B. CDK1-
cyclin-B breaks down the nuclear envelope and allows chromatin to condense with the help of the 
condensing complex  and DNA topoisomerase II (TOPII: Wollmann et al., 2007; Malumbres and 
Barbacid, 2009). The condensed chromosomes align in the middle of the cell during the transition from 
premetaphase to the third step of mitosis, metaphase.  Cell progression up until metaphase is driven by 
CDK1-cyclin B. Afterwards, progression involves the anaphase-promoting complex (APC). APC is an 
ubiquitin-protein ligase which ubiquitinates many regulatory proteins for proteasome degradation 
(Sullivan and Morgan, 2007; Yanagida, 2009). In metaphase, the spindles get retracted and begin to be 
pulled to the poles of the cell by the kinetochore-associated microtubule as they transition to anaphase. 
The APC ubiquitinates securin which causes it to be degraded and removed from the protease called 
separase. Separase then cleaves the protein cohesin which allows for sister chromatids to separate to the 
opposite poles of a cell (Hagting et al., 2002; Yanagida, 2009).  During cytokinesis, the CDKs in the cell 
are dephosphorylated by phosphatases which influences the disassembly of spindles, the formation of 
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nuclei and the decondensation of chromatin allowing for the completion of the cell-cycle (Sullivan and 
Morgan, 2007; Malumbres and Barbacid, 2009; Yanagida, 2009). 
1.2 Checkpoint proteins 
Checkpoints are present during the cell-cycle to ensure that future events in the cell-cycle are not hindered 
due to previous events (Hartwell and Weinert, 1989). There are 4 checkpoints: (1) G1/S checkpoint; (2) 
Intra-S checkpoint; (3) G2/M checkpoint; (4) spindle assembly checkpoint (SAC: (Sancar et al., 2004; 
Clarke and Allan, 2009). The details of each checkpoint will be discussed in section 1.3.  Cell-cycle 
checkpoints operate via a signal transduction pathway involving proteins, termed “checkpoint proteins”.  
Checkpoint proteins are organized into 4 different categories based on their function: (1) sensors; (2) 
mediators; (3) transducers; (4) effectors.  The categories are used to simplify a rather complex 
biochemical pathway and it should be noted that many proteins have ubiquitous functions in the cell-
cycle. Checkpoint proteins are involved in cross-talking mechanism and function in different groups. A 
breakdown of the four different categories and some of the major players involved is provided below. 
1.2.1 Sensors 
Sensors directly or indirectly recognize DNA damage or cellular abnormalities and parlay the information 
to the mediators (Sancar et al., 2004; Niida and Nakanishi, 2006).  Different sensor proteins are activated 
depending on the damage; examples include, single-stranded and double-stranded DNA breaks (Nyberg 
et al., 2002).  The 9-1-1 complex is a heterotrimeric ring composed of three evolutionary conserved 
proteins Rad9, Rad1 and Hus1 (9-1-1) and is grouped as a sensor protein. The complex is loaded onto 
DNA by the RAD17-RFC complex and its interaction has been shown to be active in damaged and 
undamaged cells (Parrilla-Castellar et al., 2004). Upon detecting damage, the 9-1-1 complex has been 
shown to phosphorylate other checkpoint proteins; for example, in response to UV damage the 9-1-1 
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complex phosphorylates the serine/threonine-protein kinase Chk1 (Venclovas et al., 2002; Parrilla-
Castellar et al., 2004).  
1.2.2 Mediators 
Mediators function as a molecular bridge from the sensors to the transducers to complete checkpoint 
activation and DNA repair. Four main types of mediator proteins in mammals contain twin BRCA1 C-
terminus repeat (BRCT) domains and it is this unique domain that allows for protein-phosporylation 
interactions (Sancar et al., 2004; Niida and Nakanishi, 2006; Wilson and Stern, 2008). Furthermore, 
BRCT proteins mediate a damage response by attracting proteins of interest, such as ataxia telangiectasia 
mutated ATM, to the site without directly recruiting them (Eliezer et al., 2009). The p53 binding protein 1 
(53BP1) and the mediator of DNA damage checkpoint 1 (MDC1) are required for the repair of DNA 
break sites as well as in the regulation of mitosis (Eliezer et al., 2009). Breast cancer susceptibility gene 1 
(BRCA1) is a tumor suppressor gene that participates in multiple DNA repair pathways and plays a 
pivotal role as a mediator (Niida and Nakanishi, 2006; Reguart et al., 2008). 
1.2.3 Transducers 
Transducers initiate a molecular cascade which amplifies the signal to the effectors. They are mainly a 
group of kinases, which includes the phosphoinositide 3-kinase related kinases (PIKKs) ATM and ATR 
(Ataxia Telangiectesia Rad3-related) and the serine-threonine kinases CHK1 and CHK2 (Sancar et al., 
2004; Niida and Nakanishi, 2006). ATM and ATR are large proteins that work by phosphorylating many 
substrates involved in the checkpoint pathway. ATM phosphorylates CHK2 during a double-stranded 
DNA break (DSB) response, while ATR, with the help of the ATR-Interacting-Protein (ATRIP), 
phosphorylates CHK1 in a single-stranded DNA break (SSB) response. CHK1/CHK2 phosphorylate 





Effectors phosphorylate and dephosphorylate CDKs thereby controlling the transition stages of the cell-
cycle. There are three phosphotyrosine phosphatases, Cdc25-A, Cdc25-B and Cdc25-C, and a 
transcriptional factor protein, p53, which are the main effectors in human checkpoints. Cdc25 group of 
proteins dephosphorylate CDKs and directly disrupt cell-cycle transitions. While p53 is a transcription 
factor that promotes the expression of CDK inhibitors (Sancar et al., 2004). 
1.3 Cell-cycle checkpoints 
The cell-cycle checkpoints are important in preserving the integrity of the DNA from DNA damaging 
agents and from an erroneous repair mechanism. There are 4 checkpoints: (1) G1/S checkpoint; (2) Intra-
S checkpoint; (3) G2/M checkpoint; (4) spindle assembly checkpoint (SAC). Figure 1.2 is a diagrammatic 
representation of the G1/S, Intra-S and G2/M checkpoints. The G1/S checkpoint ensures that proper 
origin firing is prepared and that DNA is not damaged. The Intra-S checkpoint prevents damaged DNA 
from replication and blocks replication if synthesis is unusual; i.e. replication fork stalling. G2/M 
checkpoint prepares necessary adjustments for mitosis and is the last line of defense for the prevention of 
damaged DNA. The SAC ensures proper spindle attachment to the kinetochore for the separation of sister 
chromatid (Sancar et al., 2004; Clarke and Allan, 2009). If the repair mechanisms cannot isolate the 
problem then the cell will undergo apoptosis or cell suicide.  
1.3.1 G1/S checkpoint 
If DNA damage is detected then the cell becomes arrested which prevents the firing of replication origins 
until the problem becomes resolved. Under normal conditions, the transition from G1 to S-phase requires 
the dephosphorylation of CDK2 which prevents the phosphorylation of CDC25A. Under SSBs and DSBs, 
two different pathways are used that involve keeping CDK2 phosphorylated to stop the transition 





Figure 1.2: A summary of the cell-cycle checkpoints: G1/S, intra-S and G2/M 
To the top left (ATM) is the pathway involved in a double stranded break response, while the pathway to 
the right (ATR) is of a single-stranded break response. The lightning rod at the top is indication of 
irradiation on DNA.  These pathways can lead to cell-cycle arrest during any of the three checkpoints, 











    In pathway 1, a DSB is recognized by the Mre11/Rad50/Nbs1 (MRN) sensor complex  sensor and 
MRN recruits ATM, in an ATP dependent manner, leading to self-phosphorylation of ATM, 
phosphorylation of MRN and phosphorylation of the variant histone H2AX (γH2AX). This subsequently 
leads to the phosphorylation of chromatin-bound proteins (Wang et al., 2000; Bucher and Britten, 2008; 
Clarke and Allan, 2009). The phosphorylated γH2AX recruits Mdc1 and together they recruit Rnf8-
Ubc12- an E3 ubiquitin ligase. Rnf8-Ubc12 ubiquitylates γH2AX and recruits the mediator proteins 
53BP1 and BRCA1(Ashwell and Zabludoff, 2008).  This causes DNA to unravel from the tightly bound 
histone complex. ATM phosphorylates the transducers CHK2 and p53 which leads to the phosphorylation 
of CDC25A leading to G1 arrest. Phosphporylated CDC25A inactivates itself leading to nuclear export 
and proteolytic ubiquitin-mediated degradation ((Bucher and Britten, 2008).  
    In pathway 2, phosphorylated p53 is stabilized and accumulates where it promotes and facilitates the 
transcription of p21 (Shimada and Nakanishi, 2006). CDK2 activity is inhibited by p21 which allows pRB 
to remain attached to E2F and transcription of DNA is prohibited (Bucher and Britten, 2008; Clarke and 
Allan, 2009; Malumbres and Barbacid, 2009). Furthermore, during SSB response, phosphorylated CHK1 
can also phosphorylate CDC25A, however, this pathway is used only past the restriction point to halt G1 
in the late stages (Ashwell and Zabludoff, 2008). 
1.3.2 Intra-S checkpoint 
The intra-S checkpoint will arrest the cell-cycle and allow for repair if the replication complex is stalled 
or if there is damaged DNA. It is the second line of defense for DNA damage not corrected in the G1-
phase. The DSB pathway (mentioned in section 1.3.1) works in parallel with the SSB pathway. To repair 
damage or to fix a stalled replication fork, a DSB response is initiated and S-phase is arrested by 
degrading CDC25A.  The SSB response occurs when ssDNA is exposed during synthesis. RPA labels 
single-stranded DNA. The 9-1-1 complex and Rad17-RFC signal to ATRIP to recruit ATR. The 9-1-1 
complex, Rad17-RFC, TopBI, and RPA signal to ATRIP and ATR to phosphorylate CHK1 which in turn 
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phosphorylates CDC25A. CDC25A becomes down-regulated when it is phosphorylated causing CDK2 
activity to be suppressed which inhibits synthesis of DNA by blocking the loading of CDC45 onto 
chromatin. CDC45 is necessary for new origin firing and without being loading onto chromatin, DNA 
synthesis is prohibited allowing for cellular repair (Parrilla-Castellar et al., 2004; Xu et al., 2009).   
1.3.3 G2/M checkpoint 
The G2/M checkpoint prepares necessary adjustments for mitosis and is the last line of defense for the 
prevention of damaged DNA. The DSB and SSB repair pathways are initiated in the same manner as 
described above except with the end goal of phosphorylating CDC25B/C to arrest the cycle. 
CHK1/CHK2 phosphorylates CDC25B/C which in turn causes it to be exported into the cytoplasm by 14-
3-3 proteins (Ashwell and Zabludoff, 2008; Malumbres and Barbacid, 2009; Wang et al., 2009). Loss of 
CDC25B/C prevents CDK1-cyclin-B activation thereby arresting G2 transition into mitosis until the 
problem is resolved (Ashwell and Zabludoff, 2008; Malumbres and Barbacid, 2009; Wang et al., 2009).  
New evidence suggests that the centrosome helps to regulate the G2/M checkpoint. It has been shown that 
various proteins involved in the cell-cycle have can traffic in and out of the centrosomes, such as CDKs, 
cyclins, p53, ATR/ATM and others (Wang et al., 2009).  
1.3.4 The spindle assembly checkpoint 
The spindle assembly checkpoint (SAC) ensures that proper attachment of chromosomes to the spindle 
microtubules has occurred as well as proper chromosome alignment during metaphase. The SAC works 
by regulating APC, the complex which transitions metaphase to telophase (Yen and Kao, 2005; 
Musacchio and Salmon, 2007; Wood et al., 2008).  The kinetochore is formed on the centromere and it 
attaches to spindle microtubules to allow for proper separation. Many kinetochore proteins are involved 
with SAC but the centromere associated protein E (CENP-E) works directly by inhibiting APC. During 
G1-phase, CENP-E is exported to the cytosol and can only begin inhibiting APC following the 
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breakdown of the nucleus during prophase (Wood et al., 2008). The mitotic checkpoint complex 
(consisting of BubR1, Bub3, Mad2 and Cdc20) works in association with CENP-E to inhibit APC until 
proper attachment has occurred. When a microtubule is connected to CENP-E the mitotic checkpoint 
complex gets phosphorylated releasing it from the kinetochore. The APC ubiquitinates cyclin-B and 
securin leading to their degradation which allows the transition of mitosis to continue. Proper attachment 
of the kinetochore with spindle microtubules represses the inhibitory signal on APC allowing for the 
proper transition past metaphase (Musacchio and Salmon, 2007). 
1.4 Cell-cycle damaging agents 
On a daily basis cells are affected by external factors that interfere with DNA integrity and the cell-cycle.  
These substances stimulate a checkpoint response signaling for cellular repair or apoptosis. Damaging 
agents have been categorized based on how they affect the cell-cycle: such as, DNA damaging agents, 
microtubule inhibitors, ribonucleotide pool depletors, topoisomerase inhibitors and antimetabolites 
(Hartwell and Kastan, 1994; Johnson and Walker, 1999). Key points explaining the categories will be 
mentioned below.  
1.4.1 DNA damaging agents 
Clastogenic agents that induce DNA cross links and or SSBs/DSBs are typically termed DNA damaging 
agents (Johnson and Walker, 1999; Li et al., 2008). For example, UV-radiation, γ-radiation and X-rays 
bombard cells with energy and cause free oxygen radicals to alter the DNA structure (Sinha and Hader, 
2002). Ionizing radiation causes thymine-dimers, thymine-cytosine-dimers and base adducts to form 
which signals a base-excision repair response in the SSB/DSB pathway. Irradiation is used often when 
studying SSB pathway because it inevitably elicits a response from checkpoint proteins (Sinha and Hader, 
2002; Stephan et al., 2009).  Bleomycin is a DNA damaging agent that creates DNA strand scissions 
leading to DSBs and a DSB response. Bleomycin induces arrest/apoptosis of G1/S/G2 phases by 
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phosphorylation of a CDC25 protein via the MRN/ATM/CHK2/p53 pathway (pathway mentioned in 
detail in section 1.3.1: Steighner and Povirk, 1990; Claussen and Long, 1999).   
1.4.2 Microtubule inhibitors 
These inhibitors disrupt the cell-cycle during M-phase which sets off the SAC response. Essentially, 
tubulin polymerization is inhibited which therefore disrupts spindle formation (Johnson and Walker, 
1999). Paclitaxel (Taxol) is a chemical that binds to microtubules and represses microtubule dynamics. 
This repression inhibits the kinetochore from binding to the spindles and arrest the cell-cycle in pre-
metaphase (Wang et al., 2009). Similar to Taxol, Colchicine is a chemical that forms a complex with β-
tubulin causing inhibition of microtubules assembly (Cerquaglia et al., 2005). 
1.4.3 Ribonucleotide pool depletors 
These chemical substances are purine nucleoside analogs that deplete ribonucleotide pools. The exact 
mechanism of action is unknown but in some way the purine nucleoside analogs interfere with 
ribonucleotide reductase and DNA polymerase which stops the extension of DNA (Nabhan et al., 2004). 
In response, the G1/S checkpoint attempts to excise the addition of the purine nucleoside analog and if the 
problem is not fixed then the intra-S checkpoint will signal for apoptosis (Johnson and Walker, 1999). 
Hydroxyurea and gemcitabine are chemicals that both deplete purine deoxyribonucleotide triphosphate 
(dNTP) pools and by doing so inhibiting ribonucleotide reductase which inhibits DNA replication 
(Johnson and Walker, 1999; Koc et al., 2004).  
1.4.4 Topoisomerase inhibitors 
The enzyme, topoisomerase, relaxes DNA from its supercoiled state by unwinding it. This process is vital 
for replication so that DNA is not compacted around its histone complex. There are two topoisomerases, 
topoisomerase I which relaxes negatively and positively supercoiled DNA domains and topoisomerase II 
which relaxes supercoiled DNA and condenses DNA during M-phase (Wang, 1991; Johnson and Walker, 
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1999). The chemical etoposide inhibits topoisomerase II by blocking the catalytic mechanism necessary 
for DNA re-ligation. This prevents enzyme turnover and therefore inhibits transcripton and replication. 
Etoposide induces high levels of cellular damage and has been termed a topoisomerase poison (Nitiss, 
2009).  
1.4.5 Antimetabolites 
Antimetabolites are chemicals that have structures that resemble metabolites and are processed in the cell 
by the same route. This prevents cell growth by outperforming proper cell functions, such as DNA 
replication. Methotrexate and 5-fluorouracil are antimetabolites that act as a metabolic decoy. These 
compounds inhibit DNA synthesis and create a p53-dependent S-phase arrest (Johnson and Walker, 1999; 
Peters et al., 2000). 
1.5 Checkpoint proteins as genotoxicity biomarkers 
Currently, there are no genotoxicity assays or biomarkers that can accurately determine the type of 
damage occurring in a cell. As mentioned above, there are a variety of ways the cell-cycle can be 
damaged and altered but an assay that determines where or how the damage has occurred doesn‟t exist.  
For example, DNA integrity is often assessed using the comet assay (Singh et al., 1988; McArt et al., 
2009).  In the comet assay, cells are encapsulated in agarose and lysed using a salt solution to remove all 
cellular components except DNA. The agarose is then subjected to electrophoresis where the DNA 
migrates based on size and charge. Undamaged DNA will run slowly and remain as the “head” while 
damaged DNA will run faster and form a “tail” similar to the head and tail of a comet. The length and 
intensity of the “tail” is what determines the severity of damage (Singh et al., 1988; McArt et al., 2009). 
The comet assay cannot specify whether or not the DNA damage is single-stranded or double-stranded; in 
the past, an alkaline and neutral method was used to determine whether the type of DNA damage was 
single or double-stranded but that method has now been debunked (Collins et al., 2008; McArt et al., 
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2009). Furthermore, one of the biggest limitations is that the comet assay is not sensitive enough to detect 
low levels of DNA damage (McArt et al., 2009).  
There is a need in biology for a genotoxicity biomarker that is able to detect low levels of single-
stranded or double-stranded DNA damage. Recent evidence suggests that checkpoint proteins can be used 
as genotoxicity biomarkers. For example, the checkpoint protein CHK2 (checkpoint kinase 2) was 
characterized in rainbow trout and used a genotoxicity biomarker (Steinmoeller et al., 2009).  The authors 
treated rainbow trout cell-lines with bleomycin (see section 1.4.1) and examined the expression levels of 
CHK2 on a western blot using polyclonal anti-rtCHK2 antibodies. Bleomycin is known to create DSBs 
and CHK2 is known to be activated during the formation of DSBs. The authors observed that expression 
levels of rainbow trout CHK2 increased with an increase of bleomycin concentration (Steinmoeller et al., 
2009). This suggests that checkpoint proteins can be used as genotoxicity biomarkers. Furthermore, since 
certain checkpoint proteins respond to a specific type of damage, i.e. CHK2 response to DSBs, then a 
variety of them could be used to determine whether there is a SSB or DSB or whether the spindles are 
attached properly during mitosis or whether a damaging agent is causing more than one event. 
1.6 Rainbow trout as a model organism 
The boom in industrialization has caused more toxicants and cell-cycle damaging agents to be released 
into the environment. A lot of these toxicants end up in the water and have been shown to have adverse 
affects on aquatic species. For example, endocrine disrupters have shown to alter the normal bodily 
functions of a fish (Johnson et al., 2007), while low concentrations of “the pill” have made an entire fish 
population sterile (Kidd et al., 2007). Oncorhynchus mykiss (rainbow trout) is often used in toxicology 
studies (Fairchild et al., 2009; Wassmur et al., 2010) and is considered a model organism (Carvan et al., 
2007). Rainbow trout are very sensitive to genotoxins which makes them good indicators for the 
surrounding wildlife (Adams et al., 1999).  Furthermore, they are easily maintained at an affordable cost 
and their size is large enough to conduct physiological experiments where enough tissue can be extracted 
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to complete assays of viability (Carvan et al., 2007). Although the genome has not yet been sequenced, a 
few genetic maps are available (Rexroad et al., 2008) and there are many rainbow trout partial and full 
sequences accessible from NCBI and The Gene Index. Most importantly, there are many rainbow trout 
cell-lines (Fryer and Lannan, 1994) which have been used in past genotoxicity studies and have been 
shown to be effective in modeling in vivo biology (Pichardo et al., 2007; Steinmoeller et al., 2009). Also, 
the use of cell-lines eliminates any ethical issues surrounding the use of whole fish in genotoxic studies.  
1.7 Research Aims 
The main objective of this project was to characterize the checkpoint proteins Rad1 and Hus1 in rainbow 
trout and to determine their potential as genotoxicity biomarkers. To do this for Rad1, the cDNA 
sequence was determined, a recombinant rtRad1 protein was purified, and polyclonal antibodies were 
made against the rtRad1 recombinant protein. Anti-rtRad1 antibodies were used in western blots to 
characterize the protein levels of Rad1 in each tissue and to determine whether or not the activity of Rad1 
is influenced when damaging agents are added to cell-lines. As for Hus1, the recombinant rtHus1 protein 
was purified and used to developed polyclonal anti-rtHus1 antibodies. The antiserum was then used to 
determine the specificity of Hus1 in each rainbow trout tissue using western blots. If these genes or 
proteins can be used as markers of genotoxicity, they will provide valuable tools for screening aquatic 









Characterization of Rad1 in Rainbow Trout 
2.1 Introduction to Rad1 
The screening of radiation-sensitive (RAD) mutants from Saccharomyces cerevisiae (Sc or budding yeast) 
led to the discovery of RAD17
Sc
, a mutant strain at loci 17 that was unable to arrest the cell-cycle in 
response to DNA damage induced by ultraviolet-light (UV: Prakash, 1976; Walworth et al., 1993).  In 
Schizosaccharomyces pombe (Sp or fission yeast), RAD mutants were also examined and a UV-sensitive 
mutant that was deficient in DNA repair and has a reduced recombination frequency, called RAD1
Sp
, was 
isolated (Grossenbacher-Grunder and Thuriaux, 1981).  Even though budding yeast and fission yeast are 
evolutionarily distant, the checkpoint mechanism involved in each yeast is conserved (Carr and Hoekstra, 








, which are 




 are checkpoint proteins involved in 
the cell-cycle and are homologs of one another (Sunnerhagen et al., 1990; Siede et al., 1996; Freire et al., 
1998).  The nomenclature of checkpoint proteins from S. pombe is used in higher eukaryotes.  
In 1998, six different research groups identified the human homolog of Rad1
Sp
, called hRad, which 
codes for a 282aa protein which has a molecular weight of 32kDa (Bluyssen et al., 1998; Dean et al., 
1998; Freire et al., 1998; Marathi et al., 1998; Parker et al., 1998; Udell et al., 1998). Four out of the five 
groups concluded that human Rad1 isoforms exist. Three of the four groups concluded that two isoforms 
exist, Rad1A and Rad1B (Freire et al., 1998; Parker et al., 1998) while the other group identified three 
isforms, Rad1A, Rad1B and Rad1C (Marathi et al., 1998).  Human Rad1A is the “canonical” sequence 
that all the other isoforms are based on and the sequence was the same from all six groups. However, 
hRad1B did not have the same sequence from all four groups, in fact, each group determined a different 
splice site for hRad1B. Furthermore, northern blots were completed by the same three groups and all three 
identified hRad1 transcripts of different sizes. The identity of Rad1 is hard to determine since past 
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literature was contradictory. For example, two groups (Freire et al., 1998; Parker et al., 1998) determined 
that the hRad1 protein sequence contains domains that suggest it has 3‟-5‟ exonuclease activity, similar to 
that of the checkpoint protein Rec1. However after conducting an assay (Parker et al., 1998) determined 
that hRad1A, but not hRad1B, possess 3‟-5‟ exonuclease activity, while (Freire et al., 1998) determined 
that hRad1A does not exhibit 3‟-5‟ exonuclease activity. The contradictions in Rad1 literature makes it 
hard to determine the exact role of Rad1, none the less, the role of Rad1 while be explored in the sections 
below.  
2.1.1 The role of Rad1 
Rad1
Sp
 has been shown to transmit information to other checkpoint proteins when DNA is damaged. In 
the presence of a DNA damaging agents ( irradiation) or a ribonucleotide pool depletory (hydroxyurea) 
the mutant  Rad1
Sp  
strain is unable to arrest the cell-cycle in S-phase or G2 (Rowley et al., 1992). This 
suggests that under normal conditions Rad1
Sp
 plays a pivotal role in the cell-cycle checkpoint response. 
Furthermore, Rad1
Sp
 comprises 3 exons which encode a 37kDa protein (Long et al., 1994). High 
transcript levels of hRad1 are seen in the testis which suggest that hRad1 is involved in meiosis which 
would be consistent with Rad17
Sc
 function (Freire et al., 1998; Marathi et al., 1998; Parker et al., 1998). 
Furthermore, hRad1 is expressed at higher levels in proliferating tissue where it is localized in the nucleus 
(Freire et al., 1998). It appears that Rad1 plays an important role in the cell-cycle since Rad1
-/-
 mice are 
embryonic lethal while Rad1
+/-
 mice had high levels of skin tumors than wild-type mice (Han et al., 
2010).  This suggest that mRad1 normally plays a role in the prevention of cancerous cells by helping 
maintain DNA integrity.  
2.1.2 Rad1 in the 9-1-1 complex 
A heterotrimeric ring composed of Rad9, Rad1 and Hus1 (9-1-1 complex) detects DNA damage and 
signals for arrest/repair (Volkmer and Karnitz, 1999). The heterotrimeric ring is similar to the PCNA 
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homotrimeric ring complex that encircles DNA and is involved in replication and post replication repair 
(Parrilla-Castellar et al., 2004; Lehmann and Fuchs, 2006). The 9-1-1 complex is present in damaged and 
undamaged cells and is loaded onto damaged DNA by RAD17-RFC clamp-complex in response to 
genotoxic stresses such as alkylation, UV light, ionizing radiation and replication inhibition (Parrilla-
Castellar et al., 2004). Research suggests that during SSBs and DSBs the 9-1-1 complex unites 
ATR/ATM to facilitate CHK1/CHK2 to arrest the cell-cycle during the intra-S and G2 checkpoints 
(Roos-Mattjus et al., 2002; Parrilla-Castellar et al., 2004; Sorensen et al., 2004). Localization of hRad1 
into nucleus from the cytoplasm is hRad9 dependent and lack of hRad9 has been shown to create an 
accumulation of hRad1 in the cytoplasm in G2-phase (Hirai and Wang, 2002).  However, it appears that 
the expression of hHus1 is dependent on hRad1 as hRad1 is believed to act as a chaperone and bind to 
hHus1 in the cytoplasm preventing its proteasomal degradation (Hirai et al., 2004).  Rad1 acting as a 
chaperone correlates with expression patterns seen in mice where Hus1 transcript levels were only present 
with Rad1 transcript levels (Wang et al., 2004).  New evidence suggests that the 9-1-1 complex is 
removed from the site of damage, in a Rad9 dependent manner, once the repair mechanisms have arrived 
(Furuya et al., 2010). Once the 9-1-1 complex is no longer needed it appears that the Jun-activation 
domain-binding protein 1 (Jab1), which is known to help with the degradation of proteins, interacts 
directly with Rad1 causing the dissociation of the 9-1-1 complex which induces the nuclear export of the 
9-1-1 complex to the cytoplasm where it is degraded by the 26 S proteasome (Huang et al., 2007).   
2.1.3 Rad1 and telomeres  
Although the exact mechanism is unknown, it appears that the 9-1-1 complex is a critical component in 
mouse and human telomeres where it helps maintain telomere length (Francia et al., 2006; Francia et al., 
2007; Meyerkord et al., 2008). The Rad1
Sp
 mutant strain, which is unable to produce the Rad1 protein, 
has shorter telomere lengths than that of wild-type. Furthermore, overexpression of the Rad1 gene caused 
a slight increase in telomere length of the Rad1
Sp
 mutant strain suggesting Rad1 may be associated with 
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another component to maintain telomere length (Dahlen et al., 1998). In fission yeast, it has been 
determined that Rad1 binds to telomeres and that it may be involved in telomere maintenance (Nakamura 
et al., 2002).  In HeLa cells it has been shown that Rad1 (possibly with the 9-1-1 complex) associates 
with telomerase, the enzyme that extends the length of telomeres (Francia et al., 2006; Francia et al., 
2007). Immortal cells avoid cellular senescence (HAYFLICK and MOORHEAD, 1961) by maintaining 
telomere length using telomerase or by activating a telomerase-independent mechanism termed 
alternative lengthening of telomeres (ALT) (Bryan et al., 1995; Bryan and Reddel, 1997). The exact 
mechanism of ALT is unknown but it appears that Rad1 (the 9-1-1 complex) is involved with some of the 
key components, such as  promyelocytic leukemia (PML) body, APBs and telomere binding proteins 
hTRF1 and hTRF2, suggesting it has a pivotal role in telomere maintenance no matter which mechanism 
is employed (Nabetani et al., 2004; Jegou et al., 2009). 
2.1.4 Rad1 in genotoxic studies 
In Xenopus, the potential phosphorylation sites of xRad1 were mapped to positions T5, T135, T215 and 
T217 (TQ motifs). The Xenopus egg extract system was used to determine that position T5 is the 
phosphorylation site of xRad1, the sequence of which is also conserved in humans, mice, and zebrafish. 
Furthermore, Xenopus Rad1 became phosphorylated in the presence of exoIII-treated plasmid but the 
phosphorylation was abrogated with the addition of caffeine, an inhibitor of phosphatidylinositol 3-
kinase-related protein kinases, giving evidence that xRad1 is phosphorylated at site T5 in an ATR-
dependent manner (Lupardus and Cimprich, 2006). Human Rad1 has been shown to become 
phosphorylated when Human K562 erythroleukemia cells were treated with the Ionizing Radiation, 4-
Nitroquinoline oxide (4-NQO) and Hydroxyurea (HU: Roos-Mattjus et al., 2002). 
Nogueira et al., (2009) treated whole Anguilla anguilla L. (European eel) with 7,12-
Dimethylbenz[a]anthracene (DMBA), which is a prototype synthetic polycyclic aromatic hydrocarbon 
(PAH) known to create bulky adducts of DNA, at high and low concentrations for a variety of days. Eels 
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were sampled prior to the addition of DMBA and 1, 3, 7, 14, 28 and 90 days after the addition of DMBA.  
The authors wanted to determine if Rad1 could be used as a genotoxicity biomarker to detect genotoxins 
in aquaculture. The expression levels of Rad1 mRNA in liver were examined using real-time qPCR and it 
was determined that Rad1 expression did not increase with the increase in DMBA.  Since the comet assay 
showed that DMBA did induce DNA damage, the authors concluded that Rad1 is not a good biomarker. 
However, the data is not conclusive since the protein levels or states were not examined and Rad1 
phosphorylation has been shown to occur in response to genotoxic damage (as stated above).  For this 
study the use of rainbow trout Rad1 (rtRad1) as a genotoxicity biomarker will be examined. 
2.2 Materials and methods 
2.2.1 Isolation of rtRad1 partial sequence from cDNA library 
A pair of gene specific primers was designed from two conserved nucleotide regions  (Rad1For1 5-
CGGGTTGAAAGTCACTGTGGAGG-3‟ and Rad1Rev2  5‟-CCTCTTCCACTTCCTCATCCGG-3‟) 
based on the alignment of two rainbow trout Rad1A expressed sequence tags [TC133098 and 
BX082263.2] with human [AJ004974.1], Atlantic salmon [TC116181] and zebrafish [NM_200898.1] 
Rad1A homologs found on Dana Fabar Gene Index, Genbank and NCBI.  PCR was performed using 
2.5µl of 10X Incubation Mix Taq Polymerase without MgCl2, 0.5µl of 10mM each dNTP mix, 1.5µl of 
25mM MgCl2, 1µl  of each primer (10µM), 0.1µl Taq DNA Polymerase (5U/µl) (MP Biomedical: Solon, 
OH), 1µl of rainbow trout head kidney cDNA library (245 ng/µl) and 16.4µl H2O.  A PCR thermocyler 
gradient (Eppendorf Mastercycler gradient: Hamburg, Germany) was used with the following conditions,  
95°C 5min, 35 cycles ( 95°C 40sec, 59°C 1min, 72°C 1min) and 72°C 15min. The PCR product was run 
on a 1% agarose gel containing 1X GelRed
TM
 (Hayward, CA) and visualized with a UV transilluminator 
and Alpha Imager HP program (Alpha Innotech Flourochem 8000 Chemiluminescence and Visable 
Imaging system: Santa Clara, CA).  The amplicon was gel purified using QIAquick Gel Extraction Kit 
 
 22 
(Qiagen: Mississauga, ON), ligated into pGEM T-easy vector according to the product manual (Promega: 
Madison, WI) and subcloned into XL1-Blue MRF‟ E.coli competent cells. Clones containing the insert 
were sequenced at the University of Waterloo core facility. The sequence was placed into BLAST to 
determine the sequence identity and aligned with the aforementioned Rad1A homolog. 
2.2.2 Isolation of rtRad1 full-length cDNA sequence 
A headkidney cDNA library was developed by Kazuhiro Fujiki and was directionally cloned into vector 
pcDNA™3.1(+) (Invitrogen: Carlsbad, CA). “Anchored PCR” was used to amplify the rest of the coding 
sequence as well as both untranslated regions of rtRad1A. Gene-specific sense (Rad1For3 5-
CCAGGAGCCAGAGGAGCC-3‟) and antisense (Rad1Rev2 5‟-CCTCTTCCACTTCCTCATCCG-3‟) 
primers were developed based on the rtRad1 partial sequence  and  „anchor‟  sense (pcDNA.T7 5‟-
CGACTCACTATAGGGAGACCCAAGC-3‟ and antisense (pcDNA.BGH 5‟ 
CTAGAAGGCACAGTCGAGGCTG-3‟) primers were developed based on the pcDNA™3.1(+) vector 
sequence (Invitrogen: Carlsbad, CA).  Primer set 2 (pcDNA.BGH and Rad1Rev2) and primer set 4 
(Rad1For3 and pcDNA.T7) were used to amplify the rest of the 5‟ and 3‟ regions, respectively. Primer 
sets were arranged so that each amplicon would have an overlapping sequence with the others. PCR was 
performed as described in section 2.2.1. The thermocyler (Bio-Rad DNA Engine: Mississauga, ON) 
conditions were as follows 95°C 5min, 36 cycles ( 95°C 40sec, 60°C 1min, 72°C 1min) and 72°C 15min). 
Procedures for cloning and sequences of each amplicon were the same as in section 2.2.1.  Using the 
BioEdit software (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) the overlapping sequences were 
spliced together to obtained the full-length rtRAD1 cDNA sequence.  The protein sequence was 
determined using the Translate tool from ExPASy (http://expasy.org/tools/dna.html). Nucleotide and 
protein sequences from human [AJ004974.1; AAC95466.1], Atlantic salmon [NM_001141832.1; 
ACI66420.1], European eel [FJ438472.1; ACO52465.1] and zebrafish [NM_200898.1; NP_957192.1] 
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Rad1A homologs were aligned with the determined rtRad1A nucleotide and protein sequences using 
ClustalW. 
2.2.3 Cloning of rtRad1 open reading frame into an expression vector 
The rainbow trout Rad1A open reading frame (ORF) was amplified using sense (Rad1-ORF.For 5‟ 
GGATCCATGCCCTTGTCTACTCAGTCTCAG- 3‟) and antisense (Rad1-ORF.Rev 
5‟AAGCTTCTACTCCTCTTCCACTTCCTCATC-3‟) primer-adapters. The restriction sites BamHI and 
HindIII were included in the sense and antisense primers, respectively. Two different restriction sites 
were used to allow for directional cloning into the pRSET(A) expression vector (Invitrogen: Carlsbad, 
CA). Furthermore, each restriction site is not present in rtRAD1 sequence therefore preventing digestion 
of the amplicon. PCR was performed using 2.5µl of 10X Incubation Mix Taq Polymerase without MgCl2, 
0.5µl of 10mM each dNTP mix, 1.5µl of 25mM MgCl2, 1.5µl  of each primer (10µM), 0.1µl Taq DNA 
Polymerase (5U/µl) (MP Biomedical: Solon, OH), 0.5µl of rainbow trout head kidney cDNA library (245 
ng/µl) and 16.9µl H2O.  The thermocyler (Bio-Rad  DNA Engine: Mississauga, ON) conditions were as 
follows 95°C 5min, 35 cycles ( 95°C 40sec, 55°C 1min, 72°C 1min) and 72°C 15min. The amplicon was 
gel-purified, cloned and sequenced as stated in section 2.1.1. 
The clone containing rtRad1 ORF (pGEM T-easy:rtRAD1) and the pRSET (A) expression vector 
(Invitrogen: Carlsbad, CA) were both digested with BamHI and HindIII restriction enzymes and run on an 
agarose gel. Bands corresponding to rtRad1ORF(B/H) and pRSET(A)(B/H) were gel purified using using 
the QIAquick Gel Extraction Kit (Qiagen: Mississauga, ON) then ligated together using T4 DNA ligase 
(Promega: Madison, WI) for 1hr at room temperature and sequenced at TCAG Sequencing Center 
(Toronto,ON) to verify that the ORF was in frame with the N-terminal 6x His-tag. The expression vector 
construct [pRSET(A):rtRAD1ORF(B/H)] was transformed into the E. coli bacterial strain, BL21 (DE3) 
pLysS (Promega: Madison, WI). During a pilot study it was revealed that over-expression of rtRAD1 was 
minimal, potentially due to codon bias. Therefore the [pRSET(A):rtRAD1ORF(B/H)] construct was 
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transformed into BL21-CodonPlus®(DE3)-RIPL strain (Stratagene: Aurora, ON)  to relieve the codon 
bias. 
2.2.4 Expression and purification of rtRad1 recombinant protein 
Overnight cultures were grown in 4ml SOB containing 50µg/ml ampicillin and 35µg/ml 
chloroamphenical at 37°C and 220rpm shaking. Two 4ml overnight cultures were used to inoculate 1L of 
SOB. At an OD600 of 0.4-0.6 cultures were induced by the addition of isopropyl-beta-D-
thiogalactopyranoside at 0.5mM. After 5h of induction, cells were harvested by centrifugation at 
10,000×g for 25min. 
Lysis buffer 1 (1X PBS (pH 7.4), 5% Triton X-100, 0.5mg Lysozyme and 5X “complete” Protease 
Inhibitor cocktail-EDTA free (Roche: Mississauga, ON) was added to the cells and then sonicated 
(Microson™ Ultra Sonic Cell Disrupter, Misonix: Farmingdale, NY) on level 5 for 1min at 4°C. The 
supernatant (i.e. soluable fraction) was collected and removed after centrifugation of cells in a Sorvall® 
RC5B Plus centrifuge (Buckinghamshire, England) at 10,000×g for 25min. Solubilizing buffer (1mM B-
mercaptoethanol, 0.5M NaCl, 20mM Tris-HCl, 1% Tween 20, 5mM Imidazole, 6M Urea, 0.5mg 
Lysozyme and 5X “complete” Protease Inhibitor cocktail-EDTA free: pH 8) was added to remaining 
pellet (i.e. insoluble fraction) and sonicated on level 5 for 1 min at 4°C and set to rotate overnight at 4°C. 
The cells were centrifuged at 10,000×g for 25min and the supernatant ( the “solubilised insoluble 
fraction”) was collected and purified using Ni-NTA Agarose (Qiagen: Mississauga, ON) as per the 
manufacturer‟s instructions. To summarize, 50ml of the “solubilised insoluable” fraction was added to 
1.5ml of equilibrated Ni-NTA resin on an econo-column (Bio-Rad Laboratories: Mississauga, ON) 4°C. 
The urea was removed from the resin by washing the column once with 10ml 4M Urea Wash (1mM B-
mercaptoethanol, 0.5M NaCl, 20mM Tris-HCl, 4M Urea: pH 8), once with 10ml 2M Urea Wash(1mM B-
mercaptoethanol, 0.5M NaCl, 20mM Tris-HCl, 2M Urea: pH 8) and once with 0M Urea Wash (1mM B-
mercaptoethanol, 0.5M NaCl, 20mM Tris-HCl: pH 8).The column was then subjected to 10 washes 
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(1mM B-mercaptoethanol , 0.5M NaCl, 20mM Tris-HCl, 30mM Imidazole: pH 8) of 10X the volume of 
the resin. The recombinant protein was eluted in five 1ml aliquots of elution buffer (1mM B-
mercaptoethanol , 0.5M NaCl, 20mM Tris-HCl, 0.5M Imidazole: pH 8). 
Each elution was separated on a 12% sodium dodecyle sulfate (SDS) gel and stained with 
Coomassie Brilliant Blue G-250 (ThermoFisher Scientific: Nepean, ON) to determine purity and 
background proteins. High purity elutions were dialyzed in 1xPBS (pH 7.4) overnight at 4°C and again in 
1XPBS (pH 7.4) the following day for 4h. A Bradford (Bio-Rad: Mississauga, ON) assay was performed 
following dialysis to determine the protein concentration. The dialyzed protein was concentrated using 
VivaSpin6 10,000 MWCO columns (Sartorius Stedim Biotech: Aubagne, France) to 1mg/ml and stored at 
-80°C. One microgram of the final batch of recombinant rtRad1 (1mg/ml) was run on a 12% SDS-PAGE 
and analyzed through Coomassie staining and western blot. Please refer to Appendix A for the western 
blot protocol. Western blots were probed with the following primary antibodies; Anti-polyhistidine 
(Sigma: St. Louis, MO), Anti-Xpress™ (Invitrogen: Carlsbad, CA), Anti-Human-Rad1A (ProteinTech 
Group: Chicago, IL- Catalog No: 11726-2-AP), and no primary antibody. Western blot results confirmed 
that the recombinant protein made was indeed rtRad1. The total amount of recombinant rtRad1 protein 
made was 21mg. 
2.2.5 Immunization of rabbits 
An emulsion of 1.2ml recombinant rtRad1A protein (1mg/ml) and 1.2ml of Freund‟s Complete Adjuvant 
(Sigma: MO, USA) was created. Two female New Zealand white rabbits (Charles River Canada: 
Wilmington, MA) were immunized subcutaneously with 200ul of the emulsion.  Prior to every boost, 
blood samples were collected from the marginal ear vein to measure antibody titres. Blood was left at 4°C 
overnight to clot and serum was separated by centrifugation at 3,000xg for 10min at 4°C (Eppendorf 
Centrifuge 5810R: Hamburg, Germany ), collected and stored at -80°C. The above process was repeated 
using Feund‟s Incomplete Adjuvant (Sigma: St. Louis, MO) every three weeks for 12 weeks. After week 
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12, the rabbits were exsanguinated by carotid cannulation and „final bleed‟ serum was stored at -80°C. 
Injections and exsanguinations were performed by Martin Ryan, the veterinary technician of the Biology 
department at the University of Waterloo. 
2.2.6 Monitoring Rad1 antibody titres 
Serum collected prior to each boost was used to assess antibody titre by performing an enzyme-linked-
immunosorbent-assay (ELISA). Each well of a 96-well plate were coated with 100ul of 10µg/ml 
recombinant rtRad1 protein diluted in coating buffer (15mM Na2CO3, 34mM NaHCO3, 0.02% NaN3, 
pH9.3) for 18hrs at room temperature. The wells were emptied and washed three times with TBS-T (Tris 
Buffer Saline and 1% Tween-20). Wells were blocked with 300µl of blocking buffer (1% bovine serum 
albumin [BSA] in TBS-T) at 37°C for 1h. The wells were emptied and washed three times as previously 
stated. Anti-rtRad1 serum was diluted in blocking buffer to 1:100, 1:500, 1:1000, 1:5000, 1:10000, 
1:50000, 1:100000 and 100µl of each dilution was added in triplicate and incubated for 1h at room 
temperature. Goat anti-rabbit IgG antibody conjugated to alkaline phosphatase (Sigma: St. Louis, MO) 
was diluted in blocking buffer to 1:5000 and 100µl was added to each well for incubation at room 
temperature for 1h. For detection, 50µl of SIGMAFAST™ p-Nitrophenyl phosphate (Sigma: St. Louis, 
MO) stock solution was added to each well and incubated in the dark for 20min at room temperature. 
Absorbance was measured at 405nm using the Versamax microplate reader and the SOFTmax PRO 2.6.1 
program (Molecular Devices: Sunnyvale, CA). Values were corrected by subtracting the background 
readings. 
2.2.7 Whole fish RNA and protein lysate preparation 
Rainbow trout (Oncorhynchus mykiss) were purchased from Silver Creek Aquaculture (ON, Canada) and 
held in well-water flow-through tanks at the University of Waterloo.  Fish were kept at 12-13°C and fed 
Classic Floating Trout 5pt Regular pellets (Martin Mills: ON, Canada) daily. Fish were then euthanized 
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by overdose with Phenoxyethanol (0.001%). Spleen, heart, gill, brain, liver, head kidney, thymus, muscle 
and gonad tissue along with eggs (when available) were extracted and placed into 10ml of RNAlater and 
stored in -20°C.  The tissues were cut into smaller pieces before adding them to the RNAlater to better 
preserve the RNA and protein. These tissues were used for both RNA and protein extractions. 
For RNA extraction, 120mg of tissue was used for RNA extraction using the “Trizol Method” 
(Appendix B). The isolated RNA was subjected to DNase disgestion and “RNA cleanup” according to the 
protocol of QIAGEN® RNeasy® mini kit  (Qiagen: Mississauga, ON). RNA concentration was 
determined using NANODROP® Spetrophotometer ND-100 (Thermo Scientific: Wilmington, DE) and 
the quality of RNA was evaluated by running 10µg of each samples on a formaldehyde-agarose gel.  The 
RNA samples were stored at -80°C. 
For protein extraction, 100mg of tissue was added to 250µl NP-40 lysis buffer (1% Nonident P40, 
50mM Tris-HCl; pH 8, 150mM NaCl) and 50µl “complete” Protease Inhibitor cocktail (Sigma: St. Louis, 
MO). The tissue was homogenized using a hand held electric pestle, sonicated (Microson™ Ultra Sonic 
Cell Disrupter, Misonix: Farmingdale, NY) at level 5 intensity for 30s and centrifuged at 13,000rpm for 
10min at 4°C in a Biofuge-Pico centrifuge (Heraeus: AZ, USA). The lysate was collected and subjected 
to a Bradford Assay. Sample Buffer (60mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 14.4mM β-
mercaptoethanol, 2% bromophenol blue) was added to create a 5ug/µl protein stock prior to storage at -
20°C. 
2.2.8 Cell-line RNA and protein lysate preparation 
RTbrain-W1 and RTgill-W1 cell-lines were obtained from Dr. Niels C. Bols (University of Waterloo). 
The cell lines were maintained in 75cm
2
 flasks at 18°C in L-15 media (Sigma: St. Louis, MO) 
supplemented with 1% penicillin-streptomycin solution (100 µg/ml streptomycin, 100 IU/ml penicillin; 
Sigma: St. Louis, MO).  RTgill-W1 and RTbrain-W1 cell-lines used in the bleomycin study (described 
below) contained 10% FBS and 15% FBS respectively. RTgill-W1 cell-lines used in the hydroxyurea 
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study (described below) did not contain any FBS.  Cells were harvested using scraper and centrifugated at 
1,000Xg. RNA was extracted from the cells using QIAGEN® RNeasy® mini kit (Qiagen: Mississauga, 
ON) according to the manufacturer‟s instructions.  Protein was extracted as stated in section 2.2.7 except 
that a handheld homogenizer was not used. 
2.2.9 Determining anti-rtRad1 specificity  
Results from the ELISA analysis of the final bleed determined that serum diluted to 1:1000 from rabbit 
1Z1 was sufficient for anti-rtRad1 to recognize rtRad1 protein. Protein lysates from rainbow trout spleen, 
gill, heart, brain, liver, head kidney, eggs, thymus and muscle were boiled with 5X sample buffer (60mM 
Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 14.4mM β-mercaptoethanol, 2% bromophenol blue) and 50µg 
of each sample was loaded, then run in four replicates on a 12% SDS-PAGE and transferred to 0.2 µm 
nitrocellulose membrane (Bio-Rad: Mississauga, ON). Western (1) was probed with Anti-actin (1:200; 
Sigma: St. Louis, MO), (2) was probed with pre-immune serum (1:1000), (3) was probed with anti-rtRad1 
(1:1000), (4) was probed with anti-rtRad1 (1:1000) that had been pre-incubated with 1mg rtRad1. 
Following washes, the blots were probed with Goat anti-rabbit IgG antibody conjugated to alkaline 
phosphatase (Sigma: St. Louis, MO) at 1:3000 and then detected with an alkaline phosphate solution (as 
stated in the Appendix) until bands became visible. The blot was visualized using a Hewlett Packard 
ScanJet 3300C (Mississauga, ON) scanner and Adobe® Photoshop® 7.0. 
2.2.10 Whole fish and cell-line tissue distribution  
Protein lysates were extracted from the same tissues described above, from three different fish. Fifty 
micrograms of each sample was run on 12% SDS-PAGE gel and used in a western blot, as described 
above. Anti-rtRad1A (1:1000) was used to detect rtRad1 in each tissue while Anti-actin (1:200; Sigma: 
St. Louis, MO) was used as a control. Following washes, the blots were probed with Goat anti-rabbit IgG 
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antibody conjugated to alkaline phosphatase (Sigma: St. Louis, MO) at 1:3000 and detected with alkaline 
phosphatase detection solution as stated in Appendix A. Blots were visualized as stated above. 
     Protein lysates were extracted from RTgill-W1, RTbrain-W1 and human embryonic kidney (HEK)-
293 cell-lines and prepared as described above. Twenty micrograms of RTgill-W1 and RTbrain-W1 and 
40µg of HEK 293 was loaded on the same gel.  The samples were run, transferred and detected as stated 
above. 
2.2.11 Rad1 mRNA distribution in rainbow trout tissues 
One microgram of spleen, heart, gill, brain, liver, head kidney, thymus, and egg RNA was transcribed into 
cDNA using  RevertAid™ H Minus First Strand cDNA Synthesis Kit (Fermentas: ON, Canada) according 
to the manufacturer‟s instructions. RT-PCR was performed using 2.5µl of 10X Incubation Mix Taq 
Polymerase without MgCl2, 0.5µl of 10mM each dNTP mix, 1.5µl of 25mM MgCl2, 1.5µl  of each primer 
(10µM), 0.1µl Taq DNA Polymerase (5U/µl) (MP Biomedical: Solon, OH), 1µl of cDNA template and 
16.4µl H2O.  The primers used were Rad1For1 and Rad1Rev2. Ten RT-PCR reactions were completed, 
one for each tissue and one for a positive and a negative control (NTC). The thermocyler (Bio-Rad  DNA 
Engine: Mississauga, ON) conditions were as follows 95°C 5min, 35 cycles ( 95°C 40sec, 59°C 1min, 
72°C 1min) and 72°C 15min. Equal amounts of each RT-PCR product (5 µl) were run on a 1% agarose 
gel containing 1X GelRed
TM
 (CA, USA) and visualized with a UV transilluminator and Alpha Imager HP 
program (Alpha Innotech Flourochem 8000 Chemiluminescence and Visable Imaging system: Santa 
Clara, CA). 
2.2.12 Bleomycin treatment on RTbrain-W1 and RTgill-W1 cell-lines 
RTbrain-W1 and RTgill-W1 cell lines were maintained in Leibovitz‟s L-15 culture medium supplemented 
with 1% penicillin-streptomycin solution (100 µg/ml streptomycin, 100 IU/ml penicillin; Sigma: St. 
Louis, MO), with 10% fetal bovine serum (FBS; Sigma: St. Louis, MO) for RTgill-W1 and 15% FBS for 
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RTbrain-W1 in 75cm2 flasks at 18°C. Cells were seeded in 25cm
2
 flasks at either 1.5 x 10
6
 (RTbrain-W1) 
or 3 x 10
6
 (RTgill-W1) cells per flask, 24 hours prior to treatment.  Cells were treated indirectly with 
20µg/ml, 100µg/ml and 200µg/ml bleomycin (final concentration: Calbiochem) in L-15 medium. Control 
cells were treated with fresh media only. Flasks were then incubated in the dark at room temperature for 
the indicated time points of exposure. Maintenance and dosage of cell-lines was completed by Michelle 
Liu from Dr. Duncker‟s lab at the University of Waterloo. 
2.2.13 Hydroxyurea treatment on RTgill-W1 cell-line 
The RTgill-W1 cell-line was treated indirectly with 200mM hydroxyurea (final concentration) in L-15 
culture medium with 1% penicillin-streptomycin solution (100 µg/ml streptomycin, 100 IU/ml penicillin; 
Sigma: St. Louis, MO). Each dish (100X15mm Petri dish) contained 2 million cells and were harvested at 
days 1, 3, and 6. The control used was an RTgill-W1 cell-line not treated with hydroxyurea and was 
harvested during the same days. Dosing and maintenance of cell cultures was completed by Fanxing Zang 
from the Dr. Bols lab at the University of Waterloo. Protein lysates were harvested and the concentration 
was determined as described above. Twenty micrograms of each sample was loaded on a 12% SDS-
PAGE and transferred as described above. Samples were detected with anti-rtRad1 (1:1000), probed with 
Goat anti-rabbit IgG antibody conjugated to alkaline phosphatase (Sigma: St. Louis, MO) at 1:3000 and 
detected as stated above. The western blots were visualized as stated previously. 
2.2.14 Determining the splice variants of rtRad1 using RT-PCR 
RT-PCR was used to determine if alternative forms of rainbow trout Rad1 exist. One microgram of RNA 
from rainbow trout heart, brain, and RTgill-W1 cell-line was transcribed into cDNA as stated above.  
Primer set A (Rad1start 5‟-GAAAGCTCAGATGGCG- 3‟ and Rad1stop 5‟-
CAATATTCCTATTCTCCCTACTC - 3‟) and primer set B (Rad1-5UTR 5‟-
GTCAACAGACTTTGATACATCAAG - 3‟ and Rad1-3UTR 5‟-CATTTGAGCCTCGTATTC -3‟) were 
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the two primer sets used. RT-PCR was performed using 2.5µl of 10X Incubation Mix Taq Polymerase 
without MgCl2, 1µl of 10mM each dNTP mix, 2µl of 25mM MgCl2, 1.5µl  of each primer (10µM), 0.15µl 
Taq DNA Polymerase (5U/µl) (MP Biomedical: Solon, OH), 1µl of cDNA template and 15.35µl  H2O. 
The thermocyler (Bio-Rad  DNA Engine: Mississauga, ON) conditions were as follows 95°C 5min, 35 
cycles ( 95°C 40sec, 59°C 1min, 72°C 1.15min) and 72°C 15min. The product (5 µl) was run on a 1% 
agarose gel containing 1X GelRed
TM
 (CA, USA) and visualized with a UV transilluminator Alpha Imager 
HP program (Alpha Innotech Flourochem 8000 Chemiluminescence and Visable Imaging system: Santa 
Clara, CA).  Another gel was made to excise the different bands present in each PCR sample. For the 
heart sample, two bands were gel excised one at 840bp and one at 668bp. For the brain sample a band at 
approximately 1.1kb and another at 900kb were excised from the gel. Lastly, two bands at around 400bp 
and one band at 840bp were excised from the RTgill-W1 samples. These bands were purified and 
sequenced as stated in section 2.1.1. The nucleotide and translated protein sequences of all the samples 
were aligned together to determine if the excised bands were Rad1 splice variants. 
2.3 Results 
2.3.1 Determining the full-length cDNA sequence of rainbow trout Rad1 
Gradient PCR was performed to amplify a 721bp fragment of Rad1 from a rainbow trout head kidney 
cDNA library (Figure 2.1). The product from the 57°C reaction was cloned and sequenced. When placed 
into BLAST it was revealed to be a rainbow trout homolog of Rad1. The 721bp sequence was used to 
develop gene-specific sense and antisense primer necessary for Anchored PCR. 
Five different primer sets were used to amplify the remaining ORF and untranslated regions (UTRs: 
Figure 2.2).  Amplicons from primer set two and four were cloned and sequenced. The size of the 
amplicons from primer sets 2 and 4 were 755bp and 795bp, respectively.  Each amplicon sequence had a 





Figure 2.1: Amplification of a 721bp portion of rtRad1 
A 721bp fragment of Rad1 was amplified from the open reading frame (ORF) of the head kidney cDNA 
library. The lanes of the 1% agarose gel are labeled according to the annealing temperature used in the 
gradient PCR reaction. The amplicon from the 57°C reaction was cloned, sequenced and it was identified 
as Rad1. Above the gel is a diagram of the Rad1 cDNA. Highlighted in blue is a visual interpretation of 
















Figure 2.2: Amplification of the full-length cDNA of  rtRad1 
Anchored PCR was used to amplify the remaining cDNA sequence of rtRad1. The lanes of the 1% 
agarose gel are labeled according to the primer sets used. Primer set 2 was used to amplify a portion of 
the remaining ORF and the 5‟UTR while primer set 4 was used to amplify the remaining ORF and the 
3‟UTR.  The size of the amplicon from primer sets 2 and 4 was 755bp and 795bp, respectively. Above the 
gel is a diagram of the Rad1 cDNA. Highlighted in blue is a visual interpretation of the amplicon‟s 
location on the diagram.  Each amplicon sequence had a section that overlapped the other. This 






Figure 2.3: Nucleotide alignment of rtRad1 and Rad1 homologs 
The cDNA sequence of rtRad1 and Rad1 homologs are aligned and the conserved regions are highlighted in colour 
(A=green, G=black, C=blue, T=red). The species names are listed to the left. 

















































































length rtRAD1 cDNA sequence, which was subsequently amplified as a single product to confirm that it 
was a real sequence (see Figure 2.3).  The isolated rtRad1 cDNA sequence was 1,110bp (excluding the 
polyA-tail) with a 5‟UTR of 94bp, a 3‟UTR of 176bp and an ORF of 840bp which encodes a 279 amino-
acid protein.  The nucleotide (Figure 2.3) and protein (Figure 2.4) sequence of rtRad1 were aligned with 
homologs which revealed conserved domains. 
2.3.2 Cloning of rtRad1 open reading frame into an expression vector 
PCR was performed to amplify the 840bp ORF of rtRAD1 (Figure 2.5). The ORF was cloned into pGEM 
T-easy vector and then digested out using the restriction sites incorporated into the ORF (BamHI and 
HindIII). The digested ORF and pRSET(A) were both gel purified (Figure 2.6A) and ligated together.  
The new construct was sequenced to confirm that proper ligation occurred and that the ORF was in frame 
with the 6XHIS and XPRESS™ epitope N-terminal tags (Figure 2.6B). The construct 
[pRSET(A):rtRAD1ORF(B/H)] was transformed into BL21-CodonPlus®(DE3)-RIPL strain (Stratagene: 
Aurora, ON) to begin over expression of rtRad1 recombinant protein. 
2.3.3 Expression and purification of rtRad1 recombinant protein 
The theoretical molecular weight of rtRad1 is 31kDa but due to the addition of the 6XHIS and Xpress™ 
epitope (3kDa) the recombinant protein ran at 34kDa (Figure 2.6). Elutions which contained a thick band 
at 34kDa and with little background were collected and stored at -80°C (Figure 2.7).  In the end, 21mg/ml 
of recombinant rtRad1 protein in 1XPBS (pH 7.4) was collected.  A Coomassie stained gel containing 
1µg/ml of the final stock of recombinant rtRad1 revealed the presence of a pure sample as there was no 
background bands present (Figure 2.8A).  Four western blots containing 1µg/ml of the final stock of 
recombinant rtRad1 were probed with (1) anti-polyhistidine (Figure 2.8B), (2) anti-Xpress™ (Figure 
2.8C), (3) anti-Human-Rad1A (Figure 2.8D) and (4) no primary antibody (Figure 2.8E) confirm that the 






Figure 2.4: Multiple protein alignment of Rad1 sequences 
The protein sequences of rtRad1 and Rad1 homologs are aligned and the conserved regions are 
highlighted. The species names are listed to the left.  An overline is used to label the predicted conserved 












Figure 2.5: Amplification of rtRad1 open reading frame 
The 840bp open reading frame (ORF) of rtRad1 was amplified using primer-adapters. The lanes of the 
1% agarose gel are a positive control (+) and the ORF of rtRad1.  Above the gel is a diagram of the Rad1 


















Figure 2.6: Ligation of rtRad1 ORF into an expression vector 
(A) The 1% agarose gel shows the digested products of rtRad1 ORF (840bp) and pRSET(A) vector 
(2.9kb) with BamHI and HindIII (B/H). Above the gel is a schematic representation of the two digested 
products being ligated together. Highlighted in blue is a visual interpretation of the amplicon‟s location.  
(B) Diagram of the ligation construct created [pRSET(A):rtRAD1ORF(B/H)].  Expected protein sizes of 









Figure 2.7: Coomassie staining of rtRad1 recombinant protein elution fractions 
Ten micrograms of each elution was run on a 12% SDS-PAGE and stained with Coomassie  
Brilliant Blue G-250.  Elution fractions 1-2 are labeled as E1 and E2, respectively. The expected size of 














Figure 2.8: Analysis of the rtRad1 recombinant protein 
One microgram of the final batch of recombinant rtRad1 was run on a 12% SDS-PAGE and analyzed 
through Coomassie staining (A) and western blot (B-E). (A) Comassie staining revealed a clear band at 
34kDa with no background proteins visible. (B) A western blot probed with Anti-polyhistidine was used 
to detect the 6XHIS-TAG on the recombinant protein (34kDa). (C) A western blot showing the detection 
of the Xpress™ epitope tag on the recombinant protein (34kDa) using the primary antibody Anti-
Xpress™. (D) A western blot probed with Anti-Human-Rad1A was used to detect the rtRad1 
recombinant protein (34kDa).  (E) Western blot showing that with no primary antibody added there were 











anti-polyhistidine, anti-Xpress™ and anti-hRad1A identified a fat band at 34kDa, a faint band at 68kDa 
and bands under 34kDa at around 30kDa, 28kDa, 27kDa, 26kDa. The thick band at 34kDa is the 
molecular weight of rtRad1 recombinant protein while the faint band at 68kDa appears to be a dimer. The 
bands below 34kDa appear to be degradation products of the rtRad1 recombinant protein. 
2.3.4 Analysis of anti-rtRad1 antibody titre 
The highly pure rtRad1 recombinant protein was used to inoculate two rabbits to develop anti-rtRad1 
antibodies. The titre was monitored prior to each boost and it was revealed that anti-rtRad1 was being 
produced at a high titre for each rabbit (Figure 2.9). For each rabbit, there was an increase in titre strength 
from boost one to boost three. However, the final bleed had a titre that was lower than that of the previous 
boost. Both rabbits produced very strong antibodies that can be used at 1:1000 dilution for western blots. 
Serum for rabbit #1 was used for all westerns as it had a little less background than rabbit #2 (data not 
shown). 
2.3.5 Determining anti-rtRad1 specificity 
Anti-rtRad1 antisera from rabbit #1 recognize protein at different molecular weights than the predicted 
size of rtRad1. To confirm that these bands are rtRad1 and to confirm the specificity of the polyclonal 
antibodies four western blots were completed. Blot one had untreated final bleed anti-rtRad1 antiserum 
(1:1000), blot two used anti-rtRad1 antiserum (1:1000) that was pre-incubated with 1mg of recombinant 
rtRad1, blot three used antiserum prior to inoculation, and blot four used an anti-actin antibody as a 
control.  Figure 2.10 shows that when anti-rtRad1 antiserum is blocked with the recombinant protein, that 
the bands around that were there prior to being blocked are absent. This is due to the excess recombinant 
protein blocking the anti-rtRad1 antibodies. This helps confirm that the bands that appear on the western 










Figure 2.9: ELISA of anti-rtRad1 antiserum samples from rabbits #1 and #2 
Serum was taken prior to each boost, as well as the final bleed, to examine the antibody‟s titre. (A) The 
dilution series of rabbit#1 shows that each boost had a high titre against the recombinant rtRad1 protein. 
(B) Serum from rabbit #2 had similar results to rabbit#1. For both rabbits, the final bleed had a titre that 



































































Figure 2.10: Analyzing the specificity of the anti-rtRad1 antibody 
Western blots were used to verify the specificity of anti-rtRad1 antibody. Rainbow trout Rad1 protein was 
detected with the anti-rtRad1 antibody (1:1000) and anti-actin (1:500) was used as a control.  Detection of 
Rad1 protein was absent when the anti-rtRad1 antiserum was pre-incubated (blocked) with 1mg of the 
recombinant rtRad1 protein.   Pre-immune antiserum detected only a few background bands. Ponceau S 





antiserum shows that there is only a small amount of background bands that appear at 54kDa. Ponceau S 
staining is shown as a loading control. 
2.3.6 Rad1 distribution in rainbow trout tissues and cell-lines 
 Rad1 protein levels were examined in different rainbow trout tissues from three different fish (Figure 
2.11).  The predicted size of rtRad1 is 31kDa but this size was never observed on any of the western blots. 
Band sizes ranging from 18kDa to 100kDa were visualized but the predicted size was never seen. In 
spleen tissue, a faint band at 18kDa and 48kDa appeared, while in heart and gill tissues only a band at 
18kDa was visible. In heart, the band at 18kDa is very intense in all three of the fish- it is also the most 
intense band seen in any of the westerns to date.  The detection of a Rad1 protein at 18kDa suggests that 
rtRad1 may be alternatively spliced into a functional protein that is almost half the size of the expected 
form.  In brain tissue a faint band appeared at 35kDa, an intense band appeared at 48kDa and sometimes 
another intense band appeared at 55kDa. Interestingly, in RTbrain-W1 only one band appears at 18kDa 
suggesting that there may be different forms of rad1 present in brain tissue than in the cell-line.  Liver had 
bands present around 48kDa and 100kDa. The band at 100kDa may potentially be rad1 in the 9-1-1 
complex that has remained associated with each other even though denaturing of proteins has occurred.  
Rad1 was never detected in head kidney, while it has been detected at low intensities at 48kDa in thymus 
and muscle.  The lane that contains lysate fromHEK-293-T had a strong band at 55kDa while RTgill-W1 
had a band at 18kDa. Ponceau S staining is shown as a loading control. 
2.3.7 Rad1 mRNA distribution in rainbow trout tissues 
RT-PCR was used to determine the rtRad1 mRNA levels, using high-quality RNA (Figure 2.12A) from 
spleen, heart, gill, brain, liver, head kidney, gonad and thymus. The primers used created an amplicon of 
721bp that was seen in each of the aforementioned tissues (Figure 2.12B).  Since only a portion of Rad1 
was amplified, the mRNA level could not accurately be calculated since there appears to be many 







Figure 2.11: Assesment of Rad1 protein levels in three adult rainbow trout 
Western blot of various rainbow trout tissue from three adult rainbow trout. Protein lysates (60µg) were 
probed with anti-rtRad1 antiserum (1:1000) and anti-actin antiserum (1:500).  Each lane is labeled with 
the sample name and the amount loaded. Ponceau S staining is shown to the right of the western blot and 
is shown  as a loading control.  The western blot labeled “Fish 2” contains protein lysates from the HEK 









Figure 2.12: Expression of Rad1 mRNA transcripts in various rainbow trout tissues 
(A) Negative stain of nitrocellulose membrane containing total RNA extracted from various rainbow trout 
tissues. Bands corresponding to the 28S and 18S rRNA are labeled. The negative stain was used to 
ascertain the quality of RNA to be used in the RT-PCR reaction. (B) The products of the RT-PCR were 
run on a 1% agarose gel and the lanes corresponding to the template cDNA used are labeled. The positive 
and negative controls were used according to the RevertAid™ H Minus First Strand cDNA Synthesis Kit 





now it is known that some form of rad1 mRNA is expressed in each of the aforementioned tissues. 
2.3.8 The effects of Bleomycin induced damage on Rad1 in RTbrain-W1 and RTgill-W1 
Rad1 has been shown to be overexpressed (Hirai et al., 2004) or phosphorylated (Lupardus and Cimprich, 
2006) in response to ssDNA or dsDNA damage. RTbrain-W1 and RTgill-W1 cells were treated with 
bleomycin at various concentrations (0μg/ml, 20μg/ml, 100μg/ml, and 200μg/ml) for 24h. Bleomycin is a 
radiomimetic agent that induces double stranded breaks (Povirk et al., 1977). In Figure 2.13, experiment 
#1 shows that the increased concentration of bleomycin had no effects on rtRad1 in RTbrain-W1 since the 
band at 18kDa appeared to remain at the same relative intensity throughout the treatment and did not shift 
to a slower molecular weight. Rad1 may not be overexpressed nor phosphorylated in RTbrain-W1 cells. 
Note that a band at 48kDa is present in brain tissue but not in RTbrain-W1. However, it appears that the 
18kDa band present in RTgill-W1 increases in intensity at 100μg/ml, and 200μg/ml. The only problem is 
that the bands are touching each other forming one large band which is impossible to quantify.  The blot 
for experiment #1 could not be replicated due to insufficient samples. 
For experiment #2, two replicates were made, one on a 12% SDS-PAGE (Figure 2.14A) and one on a 
15% SDS-PAGE (Figure 2.14B) in order to better resolve the 18kDa band.  Levels of Rad1 did not 
appear to increase in RTbrain-W1 nor in RTgill-W1. The increase in intensity of the 18kDa band in 
RTgill-W1 in experiment #1 was not seen again in experiment #2. However, it should be noted that the 
concentration loaded for the 200μg/ml bleomycin sample was lower than the others due to insufficient 
sample quantity. Note that the background bands were present in both the RTbrain-W1 and RTgill-W1 









Figure 2.13: A first study of the expression of Rad1 polypeptides in rainbow trout cell-lines exposed 
to bleomycin 
Experiment 1 had both RTbrain-W1 and RTgill-W1 cells treated with bleomycin (labelled as bleo) at 
various concentrations for 24h. The western blot was probed with anti-rtRad1 (1:1000) antiserum and 
contains samples from brain tissue, RTbrain-W1 cells treated with 0µg/ml, 20µg/ml, 100µg/ml of 
bleomycin, gill tissue, and RTgill-W1 cells treated with 0µg/ml, 20µg/ml, 100µg/ml, 200µg/ml of 










Figure 2.14: A second study of the expression of Rad1 polypeptides in rainbow trout cell-lines 
exposed to bleomycin  
Experiment 2 had both RTbrain-W1 and RTgill-W1 cells treated with bleomycin (labelled as bleo) at 
various concentrations for 24h. The western blot was probed with anti-rtRad1 (1:1000) antiserum and 
contains samples from brain tissue, RTbrain-W1 cells treated with 0µg/ml, 20µg/ml, 100µg/ml of 
bleomycin, gill tissue, and RTgill-W1 cells treated with 0µg/ml, 20µg/ml, 100µg/ml, 200µg/ml of 
bleomycin. The samples were run on a 12% SDS-PAGE (Experiment 2a) and a 15% SDS-PAGE 
(Experiment 2b) Rad1 was detected at 18kDa in the cell-lines but was detected at 48kDa in the brain 




2.3.9 The effects of hydroxyurea on Rad1 in RTgill-W1 during a 6 day time course 
Hydroxyurea (HU) is an antineoplastic drug that inhibits ribonucleotide reductase which causes a 
depletion in purine dNTP levels causing the cell-cycle to arrest in S-phase (Johnson and Walker, 1999; 
Koc et al., 2004). In HEK293-T cells, Rad1 expression levels increase slightly with the addition of HU to 
cell lines, which was the motive for using HU in this study (Hirai et al., 2004).  RTgill-W1 cells were 
treated with 200mM HU and were harvested at days one, three, and six. As shown in Figure 2.15, an 
intense band at 18kDa appears in all of the control and HU samples. A band at 21kDa appears above the 
18kDa band in days one, three and six of the control samples, but is only present in day one of the HU 
samples.  A phosphorylated protein has a slower mobility than that of the unphosphorylated form and 
therefore it appears slightly above the unphosphorylated form in a western blot. Also, it is known that 
Rad1 becomes phosphorylated during a checkpoint response (Lupardus and Cimprich, 2006). The double 
band that is visualized in Figure 2.15 may possibly be the unphosphorylated (18kDa) and phosphorylated 
(21kDa) forms of Rad1.  Since the 21kDa band disappears at day 3 of the HU dosed cells, it may be likely 
that in rainbow trout the 18kDa form of Rad1 is normally phosphorylated and becomes dephosphorylated 
when induced with a damaging agent in S-phase.  
2.3.10 Alternative splicing of rtRad1 
Real-Time PCR (RT-PCR) has been shown to be an effective method to determine the splice variants of a 
gene (Vandenbroucke et al., 2001). Here, RT-PCR was used to determine whether alternative spliced 
forms of Rad1 exist in rainbow trout. Two different primer sets were used to amplify heart, brain and 
RTgill-W1 cDNA. Primer set A amplifies Rad1 from start to stop, while primer set B amplifies Rad1 
from the 5‟UTR to the 3‟UTR (Figure 2.16A). It was important to amplify the UTR as well as the ORF to 
determine whether or not the untranslated regions of Rad1 were being spliced to form different variants.  
Amplification of the UTR did not reveal that spliced variants arise from spliced UTR (Data not shown) so 







Figure 2.15: Detection of Rad1 in a 6-day time-course of RTgill-W1 treated with 0.2M hydroxyurea 
Western blot showing a potential time dependent phosphorylation of Rad1 over 6 days of treatment with 
hydroxyurea (200mM).  Rad1 is detected at 18kDa in all the samples.  A protein at 21kDa is detected 
above the 18kDa band in the control samples (days 1, 3, 6) and the hydroxyurea samples (day 1). The 
21kDa protein may be a phosphorylated form of Rad1 that becomes dephosphorylated during a 
checkpoint response. This could explain why the band is absent in days 3 and 6 of the hydroxyurea 
























Figure 2.16: Detecting Rad1 splice variants in rainbow trout heart and brain using RT-PCR  
(A) Schematic showing which Rad1 sections primer set A and primer set B amplify. Primer set A 
amplifies the ORF from start (green circle) and stop (red circle), while primer set B amplifies the ORF 
from the 5‟UTR and 3‟UTR. (B) Primer set A was used to amplify Rad1 in heart and primer set B was 
used to amplify Rad1 in brain. The band at 840bp, labeled “A”, is the expected Rad1 ORF. The band at 





Figure 2.17: Nucleotide alignment of the Rad1 isoforms discovered in heart and brain 
The ORF nucleotide sequences of band “A” and “B” that were isolated from heart and brain are aligned. 
Conserved regions are highlighted in colour (A=green, G=black, C=blue, T=red). The dash (~) in the 
alignment represents where the sequence is missing in band “B”. 
 
10 20 30 40 50 60 70 80 90
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" atgcccttgtctactcagtctcagactgaaggtgacaactacgtccttgtagctagtctggacaatgtccggaatctgtccaacatcttg
Heart band "B" atgcccttgtctactcagtctcagactgaaggtgacaactacgtccttgtagctagtctggacaatgtccggaatctgtccaacatcttg
Brain band "A" atgcccttgtctactcagtctcagactgaaggtgacaactacgtccttgtagctagtctggacaatgtccggaatctgtccaacatcttg
Brain band "B" atgcccttgtctactcagtctcagactgaaggtgacaactacgtccttgtagctagtctggacaatgtccggaatctgtccaacatcttg
100 110 120 130 140 150 160 170 180
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" aaagctatcaccttcaaagatcatgcaattttcaatgccacaccaaacgggttgaaagtcactgtggaggactctaaatgtctgcaagcc
Heart band "B" aaagctatcaccttcaaagatcatgcaattttcaatgccacaccaaacgggttgaaagtcactgtggaggactctaaatgtctgcaagcc
Brain band "A" aaagctatcaccttcaaagatcatgcaattttcaatgccacaccaaacgggttgaaagtcactgtggaggactctaaatgtctgcaagcc
Brain band "B" aaagctatcaccttcaaagatcatgcaattttcaatgccacaccaaacgggttgaaagtcactgtggaggactctaaatgtctgcaagcc
190 200 210 220 230 240 250 260 270
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" aatgcctttattcaggctgagatcttccaggagtttaccatcaaagaggactcagtggggtttcaggtcaatctgactgttcttctggac
Heart band "B" aatgcctttattcaggctgagatcttccaggagtttaccatcaaagaggactcagtggggtttcaggtcaatctgactgttcttctggac
Brain band "A" aatgcctttattcaggctgagatcttccaggagtttaccatcaaagaggactcagtggggtttcaggtcaatctgactgttcttctggac
Brain band "B" aatgcctttattcaggctgagatcttccaggagtttaccatcaaagaggactcagtggggtttcaggtcaatctgactgttcttctggac
280 290 300 310 320 330 340 350 360
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" tgtctcaccatcttcgggggaagcacagtaccaggagtggccactgccttgcggatgtgctacaacggatatggctaccccctgaccctg
Heart band "B" tgtctcaccatcttcgggggaagcacagtaccaggagtggccactgccttgcggatgtgctacaacggatatggctaccccctgaccctg
Brain band "A" tgtctcaccatcttcgggggaagcacagtaccaggagtggccactgccttgcggatgtgctacaacggatatggctaccccctgaccctg
Brain band "B" tgtctcaccatcttcgggggaagcacagtaccaggagtggccactgccttgcggatgtgctacaacggatatggctaccccctgaccctg
370 380 390 400 410 420 430 440 450
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" ttcctagaggagggtggtgtggtgacggtgtgtaggatcaacacccaggagccagaggagcccatagactttgagttctgtagcaccaat
Heart band "B" ttcctagaggagggtggtgtggtgacgg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Brain band "A" ttcctagaggagggtggtgtggtgacggtgtgtaagatcaacacccaggagccagaggagcccatagactttgagttctgcagcaccaat
Brain band "B" ttcctagaggagggtggtgtggtgacgg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
460 470 480 490 500 510 520 530 540
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" gtgactaataaagtcatcctgcaatcagagagtctgaaggaggccttctctgagctggacatgaccagtgaggtcctgcagatcaccatg
Heart band "B" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Brain band "A" gtgactaataaagtcatcctgcaatcagagagtctgaaggaggccttctctgagctggacatgaccagtgaggtcctgcagatcaccatg
Brain band "B" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
550 560 570 580 590 600 610 620 630
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" tctcccagtcagccatactttaggttgtctacctttgggaattctgggaatgcccattatgattacccaaaagattctgacatgatggag
Heart band "B" ~~~~~~~~~~~~~~~~~~~~~~~~ttgtctacctttgggaattctgggaatgcccattatgattacccaaaagattctgacatgatggag
Brain band "A" tctcccagtcagccatactttaggttgtctacctttgggaattctgggaatgcccattatgattacccaaaagattctgacatgatggag
Brain band "B" ~~~~~~~~~~~~~~~~~~~~~~~~ttgtctacctttgggaattctgggaatgcccattatgattacccaaaagattctgacatgatggag
640 650 660 670 680 690 700 710 720
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" ctgtttcagtgcacaaagactcagactaacaggtacaagatgtctctcctgaagccgtccaccaaggccctggctctatcctgtaaggtc
Heart band "B" ctgtttcagtgcacaaagactcagactaacaggtacaagatgtctctcctgaagccgtccaccaaggccctggctctatcctgtaaggtc
Brain band "A" ctgtttcagtgcacaaagactcagactaacaggtacaagatgtctctcctgaagccgtccaccaaggccctggctctatcctgtaaggtc
Brain band "B" ctgtttcagtgcacaaagactcagactaacaggtacaagatgtctctcctgaagccgtccaccaaggccctggctctatcctgtaaggtc
730 740 750 760 770 780 790 800 810
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" tcggtgaggacagacagcagagggttcctgtctttgcagtacttggtcaggaatgatgatggacagatctgcttcgttgaatactactgc
Heart band "B" tcggtgaggacagacagcagagggttcctgtctttgcagtacttggtcaggaatgatgatggacagatctgcttcgttgaatactactgc
Brain band "A" tcggtgaggacagacagcagagggttcctgtctttgcagtacttggtcaggaatgatgatggacagatctgcttcgttgaatactactgc
Brain band "B" tcggtgaggacagacagcagagggttcctgtctttgcagtacttggtcaggaatgatgatggacagatctgcttcgttgaatactactgc
820 830 840
....|....|....|....|....|....|
Heart band "A" tgtccggatgaggaagtggaagaggagtag
Heart band "B" tgtccggatgaggaagtggaagaggagtag
Brain band "A" tgtccggatgaggaagtggaagaggagtag
Brain band "B" tgtccggatgaggaagtggaagaggagtag
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alternative spliced products in heart, brain and RTgill-W1. When amplifying the ORF in heart two 
products were revealed, one at 840bp (band A) and one at 664bp (band B: Figure 2.16). The nucleotide 
alignment (Figure 2.17) shows that the sequence of band A is that of the full rtRad1 ORF, while the 
sequence of band B is that of rtRad1 but with the removal of 176bp. The 176bp are removed from section 
388bp to 564bp of the “canonical‟ Rad1 sequence. There are 279aa and 221aa in band “A” and band “B”, 
respectively. The same spliced variant (band B) was isolated from brain cDNA(Figure 2.17). The amino-
acid sequence from bands “A” and “B” from both heart and brain were aligned together (Figure 2.18).  
The protein product from band “B” does not produce a functional protein since there is a nonsense 
mutation at amino acid position 141. 
The amplification of RTgill-W1 ORF revealed three products, one at 840bp (band A), one at 426bp 
(band C) and one at 405bp (band D: Figure 2.19). Band “C” and “D” are spliced variants of Rad1, where 
band “C” is missing 414bp from 267bp to 681bp and band “D” is missing 435bp from 102bp to 537bp 
(Figure 2.20.)  An alignment of the amino-acid sequences from bands “A”,  “C”, and  “D” reveal that 
band “C” and “D” are splice variants of Rad1 that can form functional proteins. There are 279 amino 
acids in band “A”, while there are 141aa and 134aa in band “C” and “D” respectively. The predicted 
molecular weight of band “C” and “D” are 15.7kDa and 15.1kDa which is approximately the molecular 
weight of the 18kDA band seen in many of the western blots detecting rtRad1. Figure 2.22 is a schematic 
illustrating the different splice forms of rtRad1 discovered and demonstrates that each of the variants are 
spliced at different locations. 
2.4 Discussion of rtRad1 
This is the first time the Rad1 gene has been cloned from rainbow trout. The open reading frame is 840bp 
with a predicted protein sequence of 279aa which is the same length as Rad1 in zebrafish. Rainbow trout 
Rad1 contains conserved exonuclease and leucine zipper domains which are also seen in humans, 






Figure 2.18: Protein alignment of the Rad1 isoforms isolated from heart and brain 
The protein sequences of band “A” and “B” that were isolated from heart and brain are aligned. 
Conserved regions are highlighted. Band “B” does not make a functional protein and the letter “X” at 
amino acid #130 represents where the point mutation is located. The dash (~) in the alignment represents 
where the sequence is missing in band “B”. The stop codon is indicated by a star (*). The amino-acid at 








10 20 30 40 50 60 70
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" MPLSTQSQTEGDNYVLVASLDNVRNLSNILKAITFKDHAIFNATPNGLKVTVEDSKCLQANAFIQAEIFQ
Heart band "B" MPLSTQSQTEGDNYVLVASLDNVRNLSNILKAITFKDHAIFNATPNGLKVTVEDSKCLQANAFIQAEIFQ
Brain band "A" MPLSTQSQTEGDNYVLVASLDNVRNLSNILKAITFKDHAIFNATPNGLKVTVEDSKCLQANAFIQAEIFQ
Brain band "B" MPLSTQSQTEGDNYVLVASLDNVRNLSNILKAITFKDHAIFNATPNGLKVTVEDSKCLQANAFIQAEIFQ
80 90 100 110 120 130 140
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" EFTIKEDSVGFQVNLTVLLDCLTIFGGSTVPGVATALRMCYNGYGYPLTLFLEEGGVVTVCRINTQEPEE
Heart band "B" EFTIKEDSVGFQVNLTVLLDCLTIFGGSTVPGVATALRMCYNGYGYPLTLFLEEGGVVTX~~~~~~~~~~
Brain band "A" EFTIKEDSVGFQVNLTVLLDCLTIFGGSTVPGVATALRMCYNGYGYPLTLFLEEGGVVTVCKINTQEPEE
Brain band "B" EFTIKEDSVGFQVNLTVLLDCLTIFGGSTVPGVATALRMCYNGYGYPLTLFLEEGGVVTX~~~~~~~~~~
150 160 170 180 190 200 210
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" PIDFEFCSTNVTNKVILQSESLKEAFSELDMTSEVLQITMSPSQPYFRLSTFGNSGNAHYDYPKDSDMME
Heart band "B" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LSTFGNSGNAHYDYPKDSDMME
Brain band "A" PIDFEFCSTNVTNKVILQSESLKEAFSELDMTSEVLQITMSPSQPYFRLSTFGNSGNAHYDYPKDSDMME
Brain band "B" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LSTFGNSGNAHYDYPKDSDMME
220 230 240 250 260 270 280
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Heart band "A" LFQCTKTQTNRYKMSLLKPSTKALALSCKVSVRTDSRGFLSLQYLVRNDDGQICFVEYYCCPDEEVEEE*
Heart band "B" LFQCTKTQTNRYKMSLLKPSTKALALSCKVSVRTDSRGFLSLQYLVRNDDGQICFVEYYCCPDEEVEEE*
Brain band "A" LFQCTKTQTNRYKMSLLKPSTKALALSCKVSVRTDSRGFLSLQYLVRNDDGQICFVEYYCCPDEEVEEE*










Figure 2.19: Detecting Rad1 spliced variants in RTgill-W1 cell-line using RT-PCR  
Primer set A was used to amplify Rad1 in RTgill-W1. Please refer to Figure 2.17 for schematic on primer 
set A. The band at 840bp, labeled “A”, is the expected Rad1 ORF. The band at 426bp ( labeled “C”) and 
the band at 405bp (labeled “D”) are isoforms of Rad1 which are missing 414bp and 435bp, respectively, 
from the expected Rad1 ORF.  There are other bands visible on this gel but they were at such low 








Figure 2.20: Nucleotide alignment of the Rad1 isoforms discovered RTgill-W1 
The ORF nucleotide sequences of bands “A”, “C”, and “D” isolated from RTgill-W1 are aligned. 
Conserved regions are highlighted in colour (A=green, G=black, C=blue, T=red). The dash (~) in the 
alignment represents where the sequence is missing. White background around a nucleotide signifies that 
it is not conserved amongst the other two sequences. Band “D” is in lowercase letters to better display the 
spliced areas.  
10 20 30 40 50 60 70 80
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" ATGCCCTTGTCTACTCAGTCTCAGACTGAAGGTGACAACTACGTCTTTGTAGCTAGTCTGGACAATGTCCGGAATCTGTC
RtGill-W1 band "C" ATGCCCTTGTCTACTCAGTCTCAGACTGAAGGTGACAACTACGTCCTTGTAGCTAGTCTGGACAATGTCCGGAATCTGTC
RtGill-W1 band "D" atgcccttgtctactcagtctcagactgaaggtgacaactacgtccttgtagctagtctggacaatgtccggaatctgtc
90 100 110 120 130 140 150 160
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" CAACATCTTGAAAGCTGTCACCTTCAAAGATCATGCAATTTTCAATGCCACACCAAACGGGTTGAAAGTCACTGTGGAGA
RtGill-W1 band "C" CAACATCTTGAAAGCTATCACCTTCAAAGATCATGCAATTTTCAATGCCACACCAAACGGGTTGAAAGTCACTGTGGAGG
RtGill-W1 band "D" caacatcttgaaagctatcacc~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
170 180 190 200 210 220 230 240
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" ACTCTAAATGTCTGCAAGCCAATGCCTTTATTCAGGCTGAGATCTTCCAGGAGTTTACCATCAAAGAGGACTCAGTGGGG
RtGill-W1 band "C" ACTCTAAATGTCTGCAAGCCAATGCCTTTATTCAGGCTGAGATCTTCCAGGAGTTTACCATCAAAGAGGACTCAGTGGGG
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
250 260 270 280 290 300 310 320
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" TTTCAGGTCAATCTGACTGTTCTTCTGGACTGTCTCACCATCTTCGGGGGAAGCACAGTACCAGGAGTGGCCACTGCCTT
RtGill-W1 band "C" TTTCAGGTCAATCTGACTGTTCTTCTG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
330 340 350 360 370 380 390 400
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" GCGGATGTGCTACAACGGATATGGCTACCCCCTGACCCTGTTCCTAGAGGAGGGTGGTGTGGTGACGGTGTGTAAGATCA
RtGill-W1 band "C" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
410 420 430 440 450 460 470 480
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" ACACCCAGGAGCCAGAGGAGCCCATAGACTTTGAGTTCTGCAGCACCAATGTGACTAATAAAGTCATCCTGCAATCAGAG
RtGill-W1 band "C" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
490 500 510 520 530 540 550 560
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" AGTCTGAAGGAGGCCTTCTCTGAGCTGGACATGACCAGTGAGGTCCTGCAGATCACCATGTCTCCCAGTCAGCCATACTT
RtGill-W1 band "C" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~atgtctcccagtcagccatactt
570 580 590 600 610 620 630 640
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" TAGGTTGTCTACCTTTGGGAATTCTGGGAATGCCCATTATGATTACCCAAAAGATTCTGACATGATGGAGCTGTTTCAGT
RtGill-W1 band "C" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
RtGill-W1 band "D" taggttgtctacctttgggaattctgggaatgcccattatgattacccaaaagattctgacatgatggagctgtttcagt
650 660 670 680 690 700 710 720
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" GCACAAAGACTCAGACTAACAGGTACAAGATGTCTCTCCTGAAGCCGTCCACCAAGGCCCTGGCTCTATCCTGTAAGGTC
RtGill-W1 band "C" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~AAGCCATCCACCAAGGCCCTGGCTCTATCCTGTAAGGTC
RtGill-W1 band "D" gcacaaagactcagactaacaggtacaagatgtctctcctgaagccgtccaccaaggccctggctctatcctgtaaggtc
730 740 750 760 770 780 790 800
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" TCGGTGAGGACAGACAGCAGAGGGTTCCTGTCTTTGCAGTACTTGGTCAGGAATGATGATGGACAGATCTGCTTCGTTGA
RtGill-W1 band "C" TCGGTGAGGACAGACAGCAGAGGGTTCCTGTCTTTGCAGTACTTGGTCAGGAATGATGATGGACAGATCTGCTTCGTTGA
RtGill-W1 band "D" tcggtgaggacagacagcagagggttcctgtctttgcagtacttggtcaggaatgatgatggacagacctgcttcgttgg
810 820 830 840 850 860 870 880
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" ATACTACTGCTGTCCGGATGAGGAAGTGGAAGAGGAGTAG                                        
RtGill-W1 band "C" ATACTACTGCTGTCCGGATGAGGAAGTGGAAGAGGAGTAG----------------------------------------
RtGill-W1 band "D" atactactgctgtccggatgaggaagtggaagaggagtag~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~






Figure 2.21: Protein alignment of the Rad1 isoforms isolated RTgill-W1 
The protein sequences of band “A”,  “C” and “D” that were isolated from RTgill-W1 are aligned and 
conserved regions are highlighted. The dash (~) in the alignment represents where the sequences are 
missing. The stop codon is indicated by a star (*).  The amino-acids at position 34 and 54 are valine (V) 












10 20 30 40 50 60 70
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" MPLSTQSQTEGDNYVFVASLDNVRNLSNILKAVTFKDHAIFNATPNGLKVTVENSKCLQANAFIQAEIFQ
RtGill-W1 band "C" MPLSTQSQTEGDNYVLVASLDNVRNLSNILKAITFKDHAIFNATPNGLKVTVEDSKCLQANAFIQAEIFQ
RtGill-W1 band "D" MPLSTQSQTEGDNYVLVASLDNVRNLSNILKAIT~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
80 90 100 110 120 130 140
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" EFTIKEDSVGFQVNLTVLLDCLTIFGGSTVPGVATALRMCYNGYGYPLTLFLEEGGVVTVCKINTQEPEE
RtGill-W1 band "C" EFTIKEDSVGFQVNLTVLL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
150 160 170 180 190 200 210
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" PIDFEFCSTNVTNKVILQSESLKEAFSELDMTSEVLQITMSPSQPYFRLSTFGNSGNAHYDYPKDSDMME
RtGill-W1 band "C" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~MSPSQPYFRLSTFGNSGNAHYDYPKDSDMME
220 230 240 250 260 270 280
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A" LFQCTKTQTNRYKMSLLKPSTKALALSCKVSVRTDSRGFLSLQYLVRNDDGQICFVEYYCCPDEEVEEE*
RtGill-W1 band "C" ~~~~~~~~~~~~~~~~~KPSTKALALSCKVSVRTDSRGFLSLQYLVRNDDGQICFVEYYCCPDEEVEEE*
RtGill-W1 band "D" LFQCTKTQTNRYKMSLLKPSTKALALSCKVSVRTDSRGFLSLQYLVRNDDGQTCFVGYYCCPDEEVEEE*
290 300 310 320 330 340 350
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A"                                                                       
RtGill-W1 band "C" -------------------------------------------------- -------------------
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
360 370 380 390 400 410 420
....|....|....|....|....|....|....|....|....|....|....|....|....|....|
Rtgill-W1 band "A"                                                                       
RtGill-W1 band "C" ----------------------------------------------------------------      
RtGill-W1 band "D" ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
430 440 450
....|....|....|....|....|....|..
Rtgill-W1 band "A"                                 
RtGill-W1 band "C"                                 








Figure 2.22: Schematic of the Rad1 isoforms isolated 
The schematic shows the different splice variants of Rad1 discovered from start (green circle) to stop (red 
circle). The predicted splice junctions are labeled with a black circle and the nucleotide location is 
written. Band “A” is the expected Rad1 ORF sequence and is termed the “canonical” sequence. The 
nucleotide sequence of band “B” is 664bp and there are 176bp removed from sections 388bp to 564bp. 
The predicted amino-acid sequenced contains a nonsense mutation at position 388. Band “C” is missing 
414bp from sections 267bp to 681bp and band “D” is missing 435bp from sections 102bp to 537bp. The 














cell nuclear antigen (PCNA) domains which show that Rad1 plays a role in DNA replications and repair. 
The rtRad1 protein sequence has a high identity with Rad1 sequences from higher eukaryotes: such as, 
98% identical to Salmo salar, 93% identical to Danio rerio, 79% identical to Xenopus laevis and 78% 
identical to Homo sapiens. The high level of identity shows that Rad1 is an evolutionarily conserved 
checkpoint protein.  
Characterization of Rad1 expression in rainbow trout spleen, gill, heart, brain, liver, head kidney, eggs, 
thymus and muscle tissues showed that the molecular weight of the detectable bands differs amongst the 
tissues. The expected size of rtRad1 is 31kDa but this size was never identified in any of the rainbow trout 
tissue samples where only strong bands at approximately 18kDa and 48kDa were visualized.  Not being 
able to detect Rad1 at 31kDa is strange since this size is the predicted protein size from the Rad1 
“canonical” sequence.  However, the PageRuler™ is only an estimate of protein size and proteins can run 
at different sizes on an SDS-PAGE due to post-translational modifications such as glycosylation, 
acetylation, alkylation and phosphorylation (Walsh et al., 2005).  A molecular weight of approximately 
48kDa has been seen for Rad1 previously in the literature when HEK 293T cells were transfected with a 
plasmid containing myc-hRad1 (Hirai et al., 2004). The Rad1 recombinant protein was detected with anti-
myc at around 48kDa which is 14kDa larger than the expected size of 34kDa – which includes the 1.5kDa 
myc-tag. It was mentioned that the slower migration of Rad1 could be due to modifications but the type 
of modification was not specified (Hirai et al., 2004). 
The detection of several different sized Rad1 proteins has been reported in Mus musculus (mouse: 
Freire et al., 1998). A western blot containing protein lysates from mouse brain, uterus, kidney, spleen, 
muscle, liver, heart, lung, and HeLa cells was detected with anti-Rad1 and intense bands at 19kDa, 31kDa 
and 43kDa were visualized. Figure 2.23 compares the mouse western blot with the western blot from 
rainbow trout and shows that the bands at 19kDa and 43kDa seen in mouse are similar to the 18kDa and 







Figure 2.23: Comparison of Rad1 in rainbow trout and mouse 
Western blots showing the detection of Rad1 in rainbow trout and mouse. (A) identifies the band at 
48kDa and 43kDa in rainbow trout and mouse respectively. The 48kDa band is seen in gill, brain and 
liver in rainbow trout while it is seen in all the samples, except liver, in mouse.  (B) shows the band at 
18kDa seen in heart and RTgill-W1 and RTbrain-W1 in rainbow trout and the 19kDa band seen in s. 
muscle of mouse. The type of muscle is not specified. In mouse, the expected size of Rad1, 31kDa, is 














lung and HeLa cells. The 43kDa Rad1 protein was detected in mouse brain, uterus, kidney, spleen, 
muscle, heart, lung, and HeLa cells. The authors only focus on the 31kDa Rad1 protein and suggest that 
the other bands are background. However, by comparing the western blots from Figure 2.23, it is clear to 
see that the different sized Rad1 proteins are tissue specific and that they are more than just background. 
In mouse, the 19kDa protein was detected in high abundance in s. muscle but in low abundance in the 
testis (Freire et al., 1998)), while in rainbow trout the 18kDa band was detected in high abundance in 
heart, RTgill-W1, RTbrain-W1 and in low abundance in spleen and gill.  The type of muscle used from 
mouse was not specified and only an “s.” was used to describe the type. It is possible that the “s.” is an 
acronym for “smooth” or “skeletal” muscle. If mouse skeletal muscle was used than the 19kDa Rad1 
protein detected correlates with the 18kDa protein detected in rainbow trout heart since skeletal muscle is 
present in the heart (Kilarski, 1967).  
Furthermore, the molecular weight of Rad1 in rainbow trout brain is different than that seen in 
RTbrain-W1 cell-line (Figure 2.13). In brain, a strong band at 42kDa and a faint band at 55kDa are visible 
while in the cell-lines a strong band at 18kDa is visible with bands at 25kDa, 35kDa, 54kDa, 55kDa and 
100kDa in the background. There is no evidence in the literature to explain why the in vitro results are 
different from those in vivo. However, since Rad1 has shown to play a role in telomere maintenance 
(Dahlen et al., 1998; Nakamura et al., 2002; Francia et al., 2006; Jegou et al., 2009) and the RTbrain-W1 
cell-line is immortal with active telomerase (unpublished data), then there is a possibility that different 
Rad1 isoforms may be functioning in telomere maintenance.  Future work that is needed on this topic will 
be explored in section 2.4.1. 
Different isoforms of Rad1 mRNA were isolated from rainbow trout heart, brain and in the RTgill-W1 
cell-line. A Rad1 isoform of 664bp was discovered in rainbow trout heart and brain. The 221aa protein, it 
could potential encode, is non-functional since there is a non-sense mutation at amino acid position 141. 
Two isoforms were isolated in RTgill-W1, one of 426bp which encodes for a 141aa protein and one of 
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405bp which encodes for a 134aa protein. Both proteins have a predicted molecular weight at around 
16kDa which is very close to the 18kDa protein detected in RTgill-W1 western blots. The predicted start 
and end of the deletions found in each isoform are different which suggests that alternative splicing of 
rtRad1 may play a role in producing many different Rad1 proteins, similar to the human TCL6 gene 
(Sammeth et al., 2008). Furthermore, the agarose gel containing the RT-PCR reaction amplifying the 
ORF from RTgill-W1 (Figure 2.19) shows many amplified products that could not be excised but could 
potentially be more splice variants.  Alternative splicing of a rainbow trout gene that creates a functional 
protein has been seen before with the 14-3-3 family of regulatory proteins which are involved in many 
cell-cycle pathways such as apoptosis (Wanna et al., 2010). The Teleost Alternative Splicing Database 
(http://www.animalgenome.org/catfish/tasd/index.html) is a website that allows users to search the 
archive for alternative splicing of genes in teleost (Lu et al., 2010). Rad1 is currently not listed in the 
database and therefore could not be examined.   
The 18kDa Rad1 protein appeared to increase in intensity with the increase of bleomycin on RTgill-W1 
(Figure 2.13).  The same 18kDa protein did not increase in the RTbrain-W1 samples that were dosed with 
bleomycin. However the levels could not be quantified since the bands on the western blots were touching 
each other. When the experiment was replicated this increase was not seen (Figure 2.14). When RTgill-
W1 was treated with hydroxyurea for a 6-day time-course the 18kDa protein was detected in all the 
control samples and all the hydroxyurea samples. A higher molecular weight protein at 21kDa was 
detected in days 1, 3, 6 of the control samples but only day 1 of the hydroxyurea sample. Rad1 has been 
shown to be phosphorylated in response to hydroxyurea (Roos-Mattjus et al., 2002) and in Xenopus this 
phosphorylation occurs at position T5 in an ATR-depended manner (Lupardus and Cimprich, 2006). 
Furthermore, the small isofroms isolated from RTgill-W1, band “C” and “D”, both contain the T5 
predicted phosphorylation site. Thus the 21kDa band could be a phosphorylated form of the 18kDa Rad1 
protein. Since the 21kDa protein disappears after days 3 and 6 of the hydroxyurea samples it appears that 
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Rad1 may be dephosphorylated in response to a genotoxic agent.  Furthermore, the double band that 
appears could simply be two different Rad1 polypeptides (i.e. band C and D are both detected). This is the 
first time reported that an isoform of Rad1 appears to be functional and is modified in the presence of a 
damaging agent. However, this experiment needs to be replicated and this topic will be explored in 
section 2.4.1.  
2.4.1 Future Work 
Rainbow trout Rad1 needs to be characterized more thoroughly before it can be used as a genotoxicity 
biomarker. The genomic sequence should be determined and the introns should be analyzed to determine 
the different potential splice sites. The intronic sequence can be used to make an effective probe to 
determine the gene copy number using a Southern blot.  One of the main questions is whether or not the 
18kDa protein is a product of a spliced variant or a different gene completely.  By analyzing the genomic 
sequence and after completion of a Southern blot the identity of Rad1 will be more concrete.  
Furthermore, it may be possible that there are more Rad1 isoforms still to be discovered. Hybridization 
screening of a rainbow trout cDNA library using a Rad1 probe could help identify any other Rad1 
isoforms.  A northern blot should be performed to determine the transcript levels of Rad1 in RTgill-W1, 
RTbrain-W1 and each of the rainbow trout tissues.  Probes for the northern blot can be developed based 
on different regions of the Rad1 splice variants to identify which tissue the isoforms are more abundant 
in.  
The bleomycin and hydroxyurea dose studies on RTgill-W1 should be replicated twice more to better 
identify the role of the 18kDa Rad1 protein, and the other isoforms, as a genotoxicity biomarker.  
Furthermore, a dose study using bleomcyin and hydroxyurea on whole rainbow trout should be completed 
to view the role of Rad1 in vivo.  The concentration of the damaging agent will need to be determined as 
there is no reference in the literature of a dose study using bleomycin or hydroxyurea on whole fish. It 
would be a good idea to analyze both the mRNA and protein levels of Rad1 in these dose studies.  RT-
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PCR can be used to amplify the Rad1 open reading frame from all the dosed samples to determine if there 
is a change in expression of the different isoforms. Western blots should be run side-by-side to determine 
if the protein levels correlated with the transcript levels and whether or not protein modification occurs.  
A comparison of the in vitro model to the in vivo biology is critical when developing a novel assay.   
Once the Rad1 isoforms are discovered monoclonal antibodies could be made for each recombinant 
protein. Each isoform-specific monoclonal could be labelled and immunofluorescence could be used to 
localize each isoform in the control and dosed cells. This will give a visual perspective of the role of each 
isoform in the presence of a genotoxic stress. Furthermore, transcription factors involved in telomere 
maintenance, such as TBP-related factor 1 (TRF1), could be labelled to determine if any of the Rad1 
isoforms localize with telomeres in immortal cell-lines (Nabetani et al., 2004).  
2.5 Conclusion on rtRad1 
Rainbow trout Rad1 is alternatively spliced and expression of the resultant isoforms appear to be tissue 
and cell-line specific. It appears that the Rad1 isoform expression in brain tissue is different than that of 
the RTbrain-W1 cell-line which raises a question as to why Rad1 is different between the in vivo and in 
vitro model.  One difference is that the RTbrain-W1 is an immortal cell-line that contains telomerase 
activity, while the brain cells should not be immortal. Since Rad1 from other species has been shown to 
play an important role in telomere length then it may be possible that different rtRad1 isoforms may 
function in telomere maintenance which can help explain the difference seen in brain tissue. Furthermore, 
it appears that the 18kDa Rad1 isoform may play a role in the intra-S checkpoint since bleomycin damage 
has caused the protein levels to increase. Rainbow trout Rad1 needs to be characterized further before 







Characterization of Hus1 in Rainbow Trout 
3.1 Introduction to Hus1 
Analysis of numeroust Schizosaccharomyces pombe mutants that were hydroxyurea sensitive (Hus) led to 
the discovery of Hus1, a mutant that bypassed the intra-S checkpoint and failed to arrest the cell-cycle 
when treated with hydroxyurea (Enoch et al., 1992).  Hus1 is an evolutionarily conserved checkpoint 
protein that has been identified in Homo sapiens, Mus musculus, Caenorhabditis elegans and Drosophila 
melanogaster (Dean et al., 1998). The role of Hus1 in S. pombe appears to be different than that of higher 
eukaryotes (Meyerkord et al., 2008). In S. pombe, four forms of Hus1 have been discovered, Hus1A to 
Hus1D, and evidence suggest Hus1B plays the most important during a checkpoint response(Caspari et 
al., 2000). In humans, two Hus1 paralogs have been identified, hHus1A and hHus1B, and it appears that 
both may have different roles that are equally important in the cell-cycle (Hang et al., 2002). For 
example, when hHus1B was overexpressed in HEK 293T cells the percentage of dead cells was 99.54%, 
while none died when hHus1A was overexpressed (Hang et al., 2002). This suggest that hHus1B may be 
specifically involved in the apoptosis pathway while hHus1A appears to be involved in the DNA damage 
repair pathway (Meyerkord et al., 2008; Sohn and Cho, 2009). 
3.1.1 The role of Hus1 
The role of Hus1 has been investigated more thoroughly in mice than in any other higher eukaryote and 
will be discussed below.  Evidence suggests that Hus1 plays an important role in the intra-S checkpoint 
by helping to activate ATR/CHK1 in the single-stranded DNA repair pathway (Weiss et al., 2000; Weiss 
et al., 2002; Weiss et al., 2003). This evidence is supported since mice fibroblasts that are deficient in 
Hus1 have impaired regulation of the intra-S checkpoint when exposed to camptothecin, a DNA 
damaging agent (Wang et al., 2004).  In Xenopus, the potential phosphorylation sites of xHus1 were 
 
 67 
mapped to positions S59, S219, T223 (Lupardus and Cimprich, 2006).  Please refer to section 2.1.2, to 
see the role Hus1 plays in the 9-1-1 complex (Paek and Weinert, 2010). Please refer to section 2.1 to 
review the chaperone role of hRad1 with hHus1.  
3.1.2 Hus1 and telomeres 
As explained in section 2.1.3, the 9-1-1 complex has been identified as a key player in telomere 
maintenance (Francia et al., 2007). For example, in S. pombe the Hus1 protein has been shown to 
associate with telomeres (Nakamura et al., 2002). Furthermore, Hus1-deficient mouse embryonic 
fibroblasts (MEF) cells were shown to have half the mean telomere length compared to wild-type and 
showed to have reduce telomerase activity (Francia et al., 2006). The role of Hus1 in telomere 
maintenance also correlates with results seen in C. elegans where Hus1 deficiency produces shorter 
telomeres (Hofmann et al., 2002). 
3.2 Materials and methods 
3.2.1 Cloning rtHus1 open reading frame into an expression vector 
The rainbow trout Hus1 sequence was available on NCBI [NM_001160574.1] and was used to design 
gene-specific sense (Hus1-ORF.For 5‟-GGATCCATGAAGTTCCGAGC- 3‟) and antisense (Hus1-
ORF.Rev 5‟- AAGCTTCTAGGCCACCGCTGGGATGAAGTATTGC-3‟) primer-adapters. The 
restriction sites BamH I and HindIII were included in the sense and antisense primers, respectively.  The 
above primer set would amplify the Hus1 ORF while including two different restriction sites to allow for 
directional cloning into pRSET(A) expression vector (Invitrogen: Carlsbad, CA). PCR was performed 
using 2.5µl of 10X Incubation Mix Taq Polymerase without MgCl2, 0.5µl of 10mM each dNTP mix, 1µl 
of 25mM MgCl2, 1µl  of each primer (10µM), 0.1µl Taq DNA Polymerase (5U/µl) (MP Biomedical: 
Solon, OH), 0.5µl of rainbow trout thymus cDNA library (725ng/µl) and 18.4µl H2O.  The thermocyler 
(Bio-Rad  DNA Engine: Mississauga, ON) conditions were as follows 95°C 5min, 35 cycles ( 95°C 
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45sec, 54°C 45sec, 72°C 1.15min) and 72°C 15min. The amplicon was gel-purified, cloned and 
sequenced as stated in section 2.2.1. The nucleotide sequence was translated into a protein sequence using 
the “Translate Tool” from ExPASy (http://expasy.org/tools/dna.html). The protein sequences from human 
[NM_004507.2] and house mouse [NM_008316.4] Hus1A homologs were aligned with the rtHus1 
protein sequence using ClustalW. 
The clone containing rtHus1 ORF (pGEM T-easy:rtHus1) and the pRSET (A) expression vector 
(Invitrogen: Carlsbad, CA)  were both digested with BamHI and HindIII restriction enzymes and run on 
an agarose gel. Bands corresponding to rtHus1ORF(B/H) and pRSET(A)(B/H) were gel purified using 
using the QIAquick Gel Extraction Kit (Qiagen: Mississauga, ON) then ligated together using T4 DNA 
ligase (Promega: Madison, WI)  as stated in section 2.2.3 and sequenced at TCAG Sequencing center 
(Toronto, ON) to verify that the ORF was in frame with the N-terminal 6x His-tag . The expression vector 
construct [pRSET(A):rtHus1ORF(B/H)] was transformed into into the E. coli bacterial strain, BL21 
(DE3) pLysS (Promega: Madison, WI). During a pilot study it was revealed that over-expression of 
rtHus1 was minimal, potentially due to codon bias. Therefore the [pRSET(A):rtHus1ORF(B/H)] construct 
was transformed into BL21-CodonPlus®(DE3)-RIPL strain (Stratagene: Aurora, ON) to relieve the codon 
bias. 
3.2.2 Expression and purification of rtHus1 recombinant protein 
Overnight cultures were grown in 4ml Luria-Bertani (LB) media containing 50µg/ml ampicillin, 35µg/ml 
chloroamphenical, 10µg/ml streptomycin at 37°C and 220rpm shaking. Six 4ml overnight cultures were 
used to inoculate 1L of LB. At an OD600 of 0.4-0.6 cultures were induced by the addition of isopropyl-
beta-D-thiogalactopyranoside at 0.1mM. After 18h of induction, cells were harvested by centrifugation at 
10,000×g for 25 min.  
Lysis buffer 1 (1X PBS (pH 7.4), 5% Triton X-100, 0.5mg Lysozyme and 5X “complete” Protease 
Inhibitor cocktail-EDTA free (Roche: Mississauga, ON) was added to the cells and then sonicated 
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(Microson™ Ultra Sonic Cell Disrupter, Misonix: Farmingdale, NY) on level 5 for 1min at 4°C. The 
supernatant  (i.e. soluable fraction) was collected  and removed after centrifugation of cells in a Sorvall® 
RC5B Plus centrifuge (Buckinghamshire, England) at 10,000×g for 25 min. Solubilizing buffer (1mM B-
mercaptoethanol, 0.5M NaCl, 20mM Tris-HCl, 1% Tween 20, 7.5mM Imidazole, 6M Urea, 0.5mg 
Lysozyme and 5X “complete” Protease Inhibitor cocktail-EDTA free: pH 8) was added to remaining 
pellet (i.e. insoluble fraction) and sonicated on level 5 for 1 min at 4°C and set to rotate overnight at 4°C. 
The cells were centrifuged at 10,000×g for 25 min and the supernatant ( the “solubilised insoluble 
fraction”) was collected and purified using Ni-NTA Agarose (Qiagen: Mississauga, ON) as per the 
manufacturer‟s instructions. To summarize, 50ml of the “solubilised insoluable” fraction was added to 
1.5ml of equilibrated Ni-NTA resin on an econo-column (Bio-Rad Laboratories: Mississauga, ON) 4°C. 
The column was then subjected to 8 washes (1mM B-mercaptoethanol , 0.5M NaCl, 20mM Tris-HCl, 
35mM Imidazole, 6M urea: pH 8) of 10X the volume of the resin. The recombinant protein was eluted in 
five 1ml aliquots of elution buffer (1mM B-mercaptoethanol , 0.5M NaCl, 20mM Tris-HCl, 0.5M 
Imidazole, 6M urea: pH 8) 
Each elution was separated on a 12% sodium dodecyle sulfate (SDS) gel and stained with Coomassie 
blue to determine purity and background proteins. High purity elutions were dialyzed for 3hrs in a 4M 
Urea-1XPBS solution (pH 7.4), followed by a 3hr dialysis in a 2M Urea-1XPBS solution (pH 7.4), and 
followed by 3hr dialysis in a 1M Urea-1XPBS solution (pH 7.4).  An overnight dialysis in 1XPBS (pH 
7.4) was performed at 4°C, followed by a 3hr dialysis in 1XPBS (pH 7.4) at 4°C. A Bradford (Bio-Rad: 
Mississauga, ON) assay was performed following dialysis to determine the protein concentration. The 
dialyzed protein was concentrated using VivaSpin 6 10,000 MWCO columns (Sartorius Stedim Biotech: 
Aubagne, France ) to 1mg/ml and stored at -80°C. One microgram of the final batch of recombinant 
rtHus1 (1mg/ml) was run on a 12% SDS gel and analyzed through Coomassie staining and western blots. 
Western blots using the primary antibodies (1) Anti-polyhistidine (Sigma: St. Louis, MO), (2) Anti-
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Xpress™ (Invitrogen: Carlsbad, CA), (3) Anti-Human-Hus1A (ProteinTech Group: Chicago, IL- Catalog 
No: 11223-1-AP), (4) no primary antibody were used to confirm that the recombinant protein made was 
indeed rtHus1. The total amount of recombinant rtHus1 protein made was 17mg. 
3.2.3 Immunization of rabbits and monitoring antibody titre.  
Two female New Zealand white rabbits (Charles River Canada: Wilmington, MA) were inoculated with 
recombinant rtHus1 exactly as was described in section 2.2.5. The same procedures were used for each 
boost and titre check as were described in section 2.2.6. 
3.2.4 Determining anti-rtHus1 antibody specificity 
Results from the final bleed ELISA determined that serum diluted to 1:1000 from rabbit 1D1 was 
sufficient for anti-rtHus1 to recognize rtHus1 protein.  The protein samples used were those mentioned in 
section 2.2.7. Protein lysates from rainbow trout spleen, heart, gill, brain, liver, head kidney, sperm, 
thymus and RTgill-W1 were boiled with 5X sample buffer (60mM Tris-HCl, pH 6.8, 25% glycerol, 2% 
SDS, 14.4mM β-mercaptoethanol, 2% bromophenol blue) and 5µg of each sample was loaded, run in four 
replicates on 12% SDS-PAGE gel, and transferred to 0.2 µm nitrocellulose membrane Bio-Rad: 
Mississauga, ON. Please refer to the Appendix section for the western blot protocol. The western blot 
membrane (1) was probed with Anti-actin (1:200; Sigma: MO, USA), (2) was probed with pre-immune 
serum (1:1000), (3) was probed with anti-rtHus1 (1:1000), (4) was probed with anti-rtHus1 (1:1000) that 
had been pre-incubated with 1mg of rtHus1 protein. Following the washes, the blots were probed with 
Goat anti-rabbit IgG antibody conjugated to alkaline phosphatase (Sigma, St. Louis, MO) at 1:3000 and 
detected with  alkaline phosphatase detection solution. The blot was visualized using a Hewlett Packard 
ScanJet 3300C (Mississauga, ON) scanner and Adobe® Photoshop® 7.0. 
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3.2.5 Hus1 mRNA distribution in rainbow trout tissues 
One microgram of spleen, heart, gill, brain, liver, head kidney, and RTgill-W1 cell-line RNA was 
transcribed into cDNA using  RevertAid™ H Minus First Strand cDNA Synthesis Kit (Fermentus: On, 
Canada) according to the manufacturer‟s instructions. RT-PCR was performed using 2.5µl of 10X 
Incubation Mix Taq Polymerase without MgCl2, 1µl of 10mM each dNTP mix, 1.5µl of 25mM MgCl2, 
1.5µl  of each primer (10µM), 0.1µl Taq DNA Polymerase (5U/µl) (MP Biomedical: Solon, OH), 1µl of 
cDNA template and 15.9µl of H2O.  The sense (Hus1For2 5‟-CGTCAGTCGTGTTGTCACCCATG-3‟) 
and antisense (Hus1Rev2 5‟-GGCCACCGCTGGGATGAAG -3‟) primers were designed to amplify a 
503bp fragment. The thermocyler (Bio-Rad  DNA Engine: Mississauga, ON) conditions were as follows 
95°C 5min, 30 cycles (95°C 40sec, 58°C 1min, 72°C 1.15min) and 72°C 15min. Equal amounts of  each 
product (1 µl) were run on a 1% agarose gel containing 1X GelRed
TM
 (Hayward, CA) visualized with a 
UV transilluminator and Alpha Imager HP program (Alpha Innotech Flourochem 8000 
Chemiluminescence and Visable Imaging system: Santa Clara, CA). 
3.3 Results 
3.3.1 Cloning of rtHus1 open reading frame into an expression vector 
PCR was performed to amplify the 852bp ORF of rtHus1 (Figure 3.1). A protein alignment with the 
rtHus1 ORF, H. sapiens and M. musculus Hus1 orthologs revealed highly conserved regions (Figure 3.2). 
The ORF was cloned into pGEM T-easy vector and then digested out using the restriction sites 
incorporated into the primers (BamHI and HindIII). The digested ORF and pRSET(A) were both gel 
purified and ligated together; using methods previously described for rtRad1 (Figure 2.6).  The new 
construct was sequenced to confirm that proper ligation occurred and it was determined that the ORF was 
in frame with the 6XHIS and XPRESS™ epitope tag (Figure 3.2). The construct 
[pRSET(A):rtHus1ORF(B/H)] was transformed into BL21-CodonPlus®(DE3)-RIPL strain (Stratagene: 












Figure 3.1: Amplification of rtHus1 open reading frame 
The 852bp open reading frame (ORF) of rtHus1 was amplified using primer-adapters. The lanes of the 





















Figure 3.2: Hus1 protein alignment and diagram of the rtHus1 expression vector construct  
(A) The protein sequences of rtHus1 and Hus1 homologs are aligned and the conserved regions are 
highlighted. The species names are listed to the left.  (B) Diagram of the ligation construct created 
[pRSET(A):rtHus1ORF(B/H)].  Expected protein sizes of the N-terminal tags, rtHus1 ORF and the 
expected size of the rtHus1 recombinant protein are labeled.  
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3.3.2 Expression and purification of rtHus1 recombinant protein 
The theoretical molecular weight of rtHus1 is 33kDa but due to the addition of the 6XHIS and Xpress™ 
epitope (3kDa) the recombinant protein ran at 36kDa (Figure 3.2B). Elutions which contained a thick 
band at 36kDa and with little background were collected and stored at -80°C (Figure 3.3).  In the end, 
18mg/ml of recombinant rtHus1 protein in 1XPBS (pH 7.4) was collected.  A Coomassie stained gel 
containing 1µg/ml of the final stock of recombinant rtHus1 revealed the presence of a pure sample as 
there was no background bands present (Figure 3.4A).  Four western blots containing 1µg/ml of the final 
stock of recombinant rtHus1 were probed with (1) anti-polyhistidine(Figure 3.4B), (2) anti-Xpress™ 
(Figure 3.4C) , (3) anti-Human-Hus1A (Figure 3.4D) and (4) no primary antibody (Figure 3.4E) confirm 
that the recombinant protein made was indeed rtHus1 and it was highly pure (Figure 3.4). The western 
blots from anti-polyhistidine, anti-Xpress™ identified a thick intense band at 36kDa which is the 
expected size of the recombinant rtHus1 protein. The anti-hHus1A western blot revealed two bands, one 
at 29kDa and one at 45kDa, which may represent cross reactivity with non-specific proteins. None the 
less, there was a strong 36kDa band visible in the coomassie stained gel and in the anti-polyhistidine and 
anti-Xpress western blots. 
3.3.3 Analysis of anti-rtHus1 antibody titre 
The highly pure rtHus1 recombinant protein was used to inoculate two rabbits to develop anti-rtHus1 
antibodies. The titre was monitored prior to each boost and it was revealed that anti-rtHus1 was being 
produced at a high titre for each rabbit (Figure 3.5).  For each rabbit, there was an increase in titre 
strength from boost one to boost three. However, the final bleed had a titre that was lower than that of the 
previous boost. Both rabbits produced very strong antibodies that can be used at 1:1000 dilution for 
western blots. Serum for rabbit #1 was used for all westerns as it had a little less background than rabbit 











Figure 3.3: Coomassie staining of rtHus1 recombinant protein elution fractions 
Ten micrograms of each elution was run on a 12% SDS-PAGE and stained with Coomassie  
Brilliant Blue G-250.  Elution fractions 1-2 are labeled as E1 and E2, respectively. The expected size of 















Figure 3.4: Analysis of the rtHus1 recombinant protein 
One microgram of the final batch of recombinant rtHus1 was run on a 12% SDS-PAGE and analyzed 
through Coomassie staining (A) and western blot (B-E). (A) Comassie staining revealed a clear band at 
36kDa with no background proteins visible. (B) A western blot probed with Anti-polyhistidine was used 
to detect the 6XHIS-TAG on the recombinant protein (36kDa). (C) A western blot showing the detection 
of the Xpress™ epitope tag on the recombinant protein (36kDa) using the primary antibody Anti-
Xpress™. (D) A western blot probed with Anti-Human-Hus1A was used to detect the rtHus1 
recombinant protein. A 36kDa band was not detected but rather proteins at 29kDa and one at 45kDa were 




















Figure 3.5: ELISA of anti-rtHus1 antiserum samples from rabbits #1 and #2 
Serum was taken prior to each boost, as well as the final bleed, to examine the antibody‟s titre. (A) The 
dilution series of rabbit#1 shows that each boost had a high titre against the recombinant rtHus1 protein. 
(B) Serum from rabbit #2 had similar results to rabbit#1. For both rabbits, the final bleed had a titre that 























































3.3.4 Determining anti-rtHus1 specificity 
Anti-rtHus1 antiserum from rabbit #1 recognizes protein at different sizes than the predicted size of 
rtHus1. To confirm that these bands are rtHus1 and to confirm the specificity of the polyclonal antibodies 
four western blots were completed. Blot one had untreated final bleed anti-rtHus1 antiserum, blot two 
used anti-rtHus1 antiserum that was pre-incubated with 1mg recombinant rtHus1, blot three used 
antiserum prior to inoculation, and blot four used anti-actin as a control. Figure 3.6 shows that when anti-
rtHus1 antiserum is blocked with the recombinant protein, that bands around 36kDa and 100kDa that 
were there prior to being blocked are no longer present. This is due to the excess recombinant protein 
blocking the anti-rtHus1 antibodies. This helps confirm that the bands that appear on the western blots 
probed with anti-rtHus1 are highly likely to be rtHus1. Furthermore, the blot with the pre-immune 
antiserum shows that there was only a small amount of background. Ponceau S staining is shown as a 
loading control. 
The predicted size of Hus1 (33kDa) was not seen in any of the tissues nor cell-lines examined.  In spleen, 
gill, liver, head kidney, sperm and RTgill-W1 no intense bands were visualized but only background 
bands. In heart and thymus an intense band at 100kDa appears whereas in brain a strong band at 36kDa 
was visible.  The band at 36kDa is close to that of the expected size and could indeed be Hus1. The 
100kDa band could be Hus1 trimers or may potentially be Hus1 in the 9-1-1 complex that has remained 
associated even though denaturing of proteins has occurred. Furthermore, the Ponceau S staining reveals 
that only a small amount of protein was loaded. The results need to be replicated to accurately depict the 
tissue distribution of Hus1 in rainbow trout. 
3.3.5 Hus1 mRNA distribution in rainbow trout tissues 
RT-PCR was used to determine the rtHus1 mRNA levels, using high-quality RNA (Figure 2.12A) from 
spleen, heart, gill, brain, liver, head kidney, RTgill-W1. The primers used created an amplicon of 503bp 






Figure 3.6: Analyzing the specificity of the anti-rtHus1 antibody 
Western blots were used to verify the specificity of anti-rtHus1 antibody. Rainbow trout Hus1 protein was 
detected with the anti-rtHus1 antibody (1:1000) and anti-actin (1:500) was used as a control.  Detection of 
Hus1 protein was absent when the anti-rtHus1 antiserum was pre-incubated (blocked) with 1mg of the 
recombinant rtHus1 protein.  Pre-immune antiserum detected only a few background bands. Ponceau S 









Figure 3.7: Expression of Hus1 mRNA transcripts in various rainbow trout tissues 
The products of the RT-PCR were run on a 1% agarose gel and the lanes corresponding to the template 
























isoforms in humans, it is likely that isoforms of Hus1 are present in rainbow trout. Therefore, calculating 
the expression levels in each tissue may not be accurate since the isoform being amplified cannot be 
determined. However, the information is useful as now it is known that some form of Hus1 mRNA is 
expressed in each of the aforementioned tissues. 
3.4 Discussion on rtHus1 
The open reading frame of rtHus1 was cloned, expressed as a recombinant protein and used to make anti-
rtHus1 polyclonal antibodies. The anti-rtHus1 antiserum works effectively at a 1:1000 dilution on western 
blots and shows little background. Different sizes of rtHus1 protein were detected in heart, brain and 
thymus suggesting that alternative forms of Hus1 may exist in rainbow trout. A 100kDa protein was 
detected in heart and thymus while a 35kDa protein was detected in the brain. The 35kDa protein is close 
to the expected rtHus1 size of 33kDa while the 100kDa protein could be trimers.  RT-PCR was used to 
amplify a portion of rtHus1 in spleen, heart, gill, brain, liver, head kidney and RTgill-W1 suggesting that 
a form of Hus1 is expressed in each of these tissues. Paralogs of Hus1 have been discovered in other 
species and these paralogs play an important role in the cell-cycle (Hang et al., 2002).  Four different 
human Hus1 transcripts were detected in a northern blot using RNA from the following samples: spleen, 
thymus, prostate, testis, uterus, small intestine, colon and leukocytes (Hang et al., 2002). Five different 
mouse Hus1 transcripts were detected in a northern blot using RNA from various sections of mouse 
embryos and mouse tissue, including spleen (Weiss et al., 1999). The detection of Hus1 in rainbow trout 
spleen correlates with the results from the human and mouse northern blots. Hus1 protein has not been 
characterized in mammalian tissues and this is the first time that Hus1 has been characterized in teleosts.  
3.4.1 Future work 
RT-PCR should be used to determine if any Hus1 splice variants exist, as well, a northern blot should be 
completed to determine the RNA transcript level. Since different sized hHus1 and mHus1 transcripts have 
 
 82 
been observed (Weiss et al., 1999; Hang et al., 2002) it is expected that different variants will exist in 
rainbow trout. Furthermore, a Southern blot needs to be completed to determine the genome copy number 
of Hus1. The expression levels of rtHus1 and any protein modifications should be monitored during a 
genotoxic study to determine the usefulness of Hus1 as a genotoxicity biomarker.  Whole rainbow trout 
and cell-lines, such as RTgill-W1 and RTbrain-W1, should be treated with hydroxyurea and the protein 
levels of rtHus1 should be examined on a western blot. Hus1 is sensitive to hydroxyurea and in Xenopus, 
Hus1 has been shown to become phosphorylated in the presence of hydroxyurea in an ATR-dependent 
manner (Lupardus and Cimprich, 2006). It is important to characterize the gene thoroughly so that it can 
better be used as a genotoxicity biomarker. 
3.5 Conclusion on rtHus1 
The use of Hus1 as a genotoxicity biomarker can be explored now that an anti-rtHus1 antibody has been 
developed. The characterization of Hus1 and any alternative spliced forms needs to be explored 
thoroughly to better understand the function of Hus1 in rainbow trout. Overall, Hus1 is a useful addition 
to the list of antibodies made from checkpoint proteins in rainbow trout and the involvement of Hus1 with 
DNA repair, the 9-1-1 complex and telomere maintenance shows that this protein plays a very important 















4.1 Future directions 
The 9-1-1 complex has been characterized in other organisms and has shown to play an important role in 
the cell-cycle checkpoints and in telomere maintenance (Roos-Mattjus et al., 2002; Parrilla-Castellar et 
al., 2004; Sorensen et al., 2004). It would be interesting to determine whether Rad9, Rad1 and Hus1 form 
the 9-1-1 complex in rainbow trout and whether the formation of the 9-1-1 complex is tissue specific. 
Furthermore, it would be fascinating to see if rtRad1 isforms or rtHus1 are able to interact with each 
other. Paralogs of Rad1 have not been characterized in the literature but a paralog of hHus1, hHus1B, is 
unable to associate with Rad9 and Rad1 and is unable to form the 9-1-1 complex (Hang et al., 2002). 
Since the cDNA sequence and polyclonal antibodies of rtRad1 and rtHus1 are available then 
characterizing the 9-1-1 complex in rainbow trout can be very easy. The rtRad1 and rtHus1 antibodies can 
be used to immunoprecipitate the 9-1-1 complex which can then be used to determine the crystal structure 
of the complex (Volkmer and Karnitz, 1999).  Furthermore, the open reading frame of rtRad9 has been 
cloned into pGEM T-easy vector (Promega: Madison, WI) and subcloned into XL1-Blue MRF‟ (data not 
shown). Since all three genes of the 9-1-1 complex (Rad9, Rad1 and Hus1) have been cloned in rainbow 
trout then they can be combined in tri-cistronic cloning and can be overexpressed. The recombinant 9-1-1 
complex can be purified and used to make anit-rt911complex antiserum. The antiserum could be used for 
genotoxic testing and could be added to the panel of checkpoint proteins used as genotoxicity biomarker. 
From an evolutionary standpoint it would be very beneficial to create a phylogenetic tree for Rad1 and 
Hus1 using the rainbow trout sequences.  It would be interesting to see how conserved these genes are 
with other teleost and mammals. Furthermore, a phylogenetic tree should be made of the different Rad1 
isoforms found in rainbow trout, humans, mouse and any other species (Dean et al., 1998). This will help 
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determine the evolution of each isoform and why it may have been kept or eliminated from species 
(Yeang, 2008).   
4.2 General conclusions 
The development of anti-rtRad1 and anti-rtHus1 polyclonal antibodies adds to the collection of antibodies 
made from rainbow trout checkpoint proteins thus far, such as CHK2 and p53. Once Rad1 and Hus1 are 
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Western Blot Protocol 
Once the SDS-PAGE has finished running it is placed in transfer buffer (25mM Tris base, 192mM 
Glycine, 20% methanol) for 20min, shaking at low speed. The 0.2 µm nitrocellulose membrane (Bio-
Rad: Mississauga, ON) is also placed in transfer buffer and this process is necessary to equilibrate the 
membrane and the SDS-PAGE. Then the following is set up on a Semi-dry transfer unit (Bio-Rad: 
Mississauga, ON) from bottom to top, thick filter (Bio-Rad: Mississauga, ON), membrane, SDS-
PAGE and thick filter paper.  A plastic tube is used to roll over each layer as to remove air bubbles 
that may interfere with the transfer. The lid is put onto the semi-dry transfer unit, according to the 
manufacturer‟s instructions, and the power source is set at 20V for 25min. After the transfer the 
membrane is stained with Ponceau S (0.1% Ponceau S and 5% glacial acetic acid)  for 10min on a 
shaker and then rinsed three times with deionized water until background staining is removed and all 
that remains stained is the protein. The stained membrane is then scanned using a Hewlett Packard 
ScanJet 3300C (Mississauga, ON) scanner and Adobe® Photoshop® 7.0. The membrane is then 
placed in blocking solution [5% Carnation skim milk powder in TBS-T (0.14M NaCl, 2.7mM KCl, 
25mM Tris, 1% Tween 20; pH 7.5)] for 1hr, shaking at room temperature as to block unoccupied 
protein sites. The blocking solution is then removed and the primary antibody (which has been diluted 
in blocking solution) is added and left in for 1hr, shaking at room temperature. After the 1hr 
incubation, the antibody is removed and the membrane is washed with TBS-T two times for 10sec, 
one time for 15min and then two times for 10min. The secondary antibody is added (usually at 1:3000 
dilution) and probed for 1hr, shaking at room temperature. After the 1hr incubation the membrane is 
washed with TBS-T once for 30sec, once for 15min and then twice at 5min. The membrane is placed 
in an alkaline phosphate (AP) detection solution [(0.1M Tris, 0.1M NaCl, 0.05M MgCl2; pH 9.5) 
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with 0.33mg/ml nitro blue tetrazolium (NBT) and 0.165 mg/ml bromochloroindolyl phosphate 







TRIzol® Method for RNA Extraction 
For RNA extraction, 120mg of tissue was placed in 1ml of TRIzol® (Invitrogen: Carlsbad, CA) and 
homogenized using a hand held electric pestle. Another 500µl TRIzol® was added and left to sit for 
5min on ice, followed by the addition of 200µl chloroform. After incubating on ice for 10min the 
samples were centrifuged at 12,000x g for 15 min 4°C. The transparent upper phase layer was 
removed and placed into a new centrifuge tube containing 500μl isopropyl alcohol. The tubes were 
inverted twice, incubated on ice for 10min then centrifuged at 12,000xg for 15 min 4°C. The 
supernatant was removed and 1ml 75% ethanol made in diethyl pyrocarbonate (DEPC) water was 
added to the RNA to remove trace elements. The sample was centrifuging at 7500xg for 5 min at 4°C 
and the supernatant was removed. Once dry, the RNA pellet was resuspended in DEPC water. The 
isolated RNA was subjected to DNase disgestion and “RNA cleanup” according to the protocol of 
QIAGEN® RNeasy® mini kit (Qiagen: Mississauga, ON). The concentration of RNA was determined 
using a NANODROP® Spetrophotometer ND-100 (Thermo Scientific: Wilmington, DE) and the 
quality of RNA was evaluated by running 10µg of each sample on a formaldehyde-agarose gel. The 
RNA samples were stored at -80°C. 
